Upgrade to SI Premium - Free Trial

Form 10-Q Dr Pepper Snapple Group, For: Mar 31

April 25, 2018 8:04 AM
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED March 31, 2018
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to     
dpsgigroupinca39.jpg           
Commission file number 001-33829
Delaware
 
98-0517725
(State or other jurisdiction of
 
(I.R.S. employer
incorporation or organization)
 
identification number)
 
 
 
5301 Legacy Drive, Plano, Texas
 
75024
(Address of principal executive offices)
 
(Zip code)
(972) 673-7000
(Registrant's telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   x No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Securities Exchange Act of 1934.
Large Accelerated Filer x
 
Accelerated Filer o
 
Non-Accelerated Filer  o
 
Smaller Reporting Company o
 
Emerging Growth Company o
 
 
(Do not check if a smaller reporting company)
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes    o   No    x

As of April 23, 2018, there were 180,221,324 shares of the registrant's common stock, par value $0.01 per share, outstanding.
 



DR PEPPER SNAPPLE GROUP, INC.
FORM 10-Q
INDEX
 
 
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

ii

Table of Contents


PART I - FINANCIAL INFORMATION
ITEM 1.
Financial Statements (Unaudited)

DR PEPPER SNAPPLE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Three Months Ended March 31, 2018 and 2017
(Unaudited)
 
 
For the Three Months Ended
 
 
March 31,
(in millions, except per share data)
 
2018
 
2017
Net sales
 
$
1,594

 
$
1,510

Cost of sales
 
681

 
607

Gross profit
 
913

 
903

Selling, general and administrative expenses
 
626

 
620

Depreciation and amortization
 
27

 
25

Other operating expense (income), net
 
1

 
(28
)
Income from operations
 
259

 
286

Interest expense
 
41

 
40

Interest income
 
(1
)
 
(1
)
Other income, net
 

 
(1
)
Income before provision for income taxes and equity in loss of unconsolidated subsidiaries
 
219

 
248

Provision for income taxes
 
54

 
71

Income before equity in loss of unconsolidated subsidiaries
 
165

 
177

Equity in loss of unconsolidated subsidiaries, net of tax
 
(6
)
 

Net income
 
$
159

 
$
177

Earnings per common share:
 
 
 
 
Basic
 
$
0.88

 
$
0.97

Diluted
 
0.88

 
0.96

Weighted average common shares outstanding:
 
 
 
 
Basic
 
179.9

 
183.4

Diluted
 
180.8

 
184.6

Cash dividends declared per common share
 
$
0.58

 
$
0.58

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


1

Table of Contents


DR PEPPER SNAPPLE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the Three Months Ended March 31, 2018 and 2017
(Unaudited)

 
For the Three Months Ended March 31,
(in millions)
2018
 
2017
Comprehensive income
$
178

 
$
200

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


2

Table of Contents


DR PEPPER SNAPPLE GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
As of March 31, 2018 and December 31, 2017
(Unaudited)
 
March 31,
 
December 31,
(in millions, except share and per share data)
2018
 
2017
Assets
Current assets:
 
 
 
Cash and cash equivalents
$
13

 
$
61

Restricted cash and restricted cash equivalents
16

 
18

Accounts receivable:
 
 
 
Trade, net
700

 
668

Other
49

 
42

Inventories
243

 
229

Prepaid expenses and other current assets
225

 
99

Total current assets
1,246

 
1,117

Property, plant and equipment, net
1,198

 
1,198

Investments in unconsolidated subsidiaries
36

 
24

Goodwill
3,564

 
3,561

Other intangible assets, net
3,784

 
3,781

Other non-current assets
286

 
279

Deferred tax assets
65

 
62

Total assets
$
10,179

 
$
10,022

Liabilities and Stockholders' Equity
Current liabilities:
 
 
 
Accounts payable
$
377

 
$
365

Deferred revenue
64

 
64

Short-term borrowings and current portion of long-term obligations
383

 
79

Income taxes payable
39

 
11

Other current liabilities
761

 
719

Total current liabilities
1,624

 
1,238

Long-term obligations
4,135

 
4,400

Deferred tax liabilities
623

 
614

Non-current deferred revenue
1,038

 
1,055

Other non-current liabilities
273

 
264

Total liabilities
7,693

 
7,571

Commitments and contingencies

 

Stockholders' equity:
 
 
 
Preferred stock, $0.01 par value, 15,000,000 shares authorized, no shares issued

 

Common stock, $0.01 par value, 800,000,000 shares authorized, 180,218,713 and 179,743,028 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively
2

 
2

Additional paid-in capital

 

Retained earnings
2,667

 
2,651

Accumulated other comprehensive loss
(183
)
 
(202
)
Total stockholders' equity
2,486

 
2,451

Total liabilities and stockholders' equity
$
10,179

 
$
10,022

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


3

Table of Contents


DR PEPPER SNAPPLE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Three Months Ended March 31, 2018 and 2017
(Unaudited)
 
For the Three Months Ended
 
March 31,
(in millions)
2018
 
2017
Operating activities:
 
 
 
Net income
$
159

 
$
177

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation expense
50

 
49

Amortization expense
9

 
11

Amortization of deferred revenue
(16
)
 
(16
)
Employee stock-based compensation expense
10

 
6

Deferred income taxes
20

 
30

Gain on step acquisition of unconsolidated subsidiaries

 
(28
)
Unrealized gains on economic hedges
11

 
(5
)
Other, net
9

 
4

Changes in assets and liabilities, net of effects of acquisition:
 
 
 
Trade accounts receivable
(30
)
 
18

Other accounts receivable
(7
)
 
5

Inventories
(13
)
 
(16
)
Other current and non-current assets
(139
)
 
(85
)
Other current and non-current liabilities
(4
)
 
(92
)
Trade accounts payable
17

 
19

Income taxes payable
27

 
20

Net cash provided by operating activities
103

 
97

Investing activities:
 
 
 
Acquisition of business
(2
)
 
(1,548
)
Cash acquired in step acquisition of unconsolidated subsidiaries

 
3

Purchase of property, plant and equipment
(41
)
 
(16
)
Purchase of intangible assets
(3
)
 
(1
)
Investment in unconsolidated subsidiaries
(19
)
 
(1
)
Proceeds from disposals of property, plant and equipment
1

 
1

Other, net
(4
)
 
(7
)
Net cash used in investing activities
(68
)
 
(1,569
)
Financing activities:
 
 
 
Net issuance of commercial paper
54

 

Repurchase of shares of common stock

 
(28
)
Dividends paid
(104
)
 
(97
)
Tax withholdings related to net share settlements of certain stock awards
(21
)
 
(30
)
Proceeds from stock options exercised
2

 
17

Deferred financing charges paid

 
(1
)
Capital lease payments
(4
)
 
(3
)
Net cash used in financing activities
(73
)
 
(142
)
Cash, cash equivalents, restricted cash and restricted cash equivalents — net change from:
 
 
 
Operating, investing and financing activities
(38
)
 
(1,614
)
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
1

 
3

Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
158

 
1,787

Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
$
121

 
$
176

See Note 13 for supplemental cash flow information.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Table of Contents


DR PEPPER SNAPPLE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
For the Three Months Ended March 31, 2018
(Unaudited)
 
 
 
 
 
 
 
 
 
Accumulated
 
 
 
Common Stock
 
Additional
 
 
 
Other
 
 
 
Issued
 
Paid-In
 
Retained
 
Comprehensive
 
Total
(in millions, except per share data)
Shares
 
Amount
 
Capital
 
Earnings
 
Loss
 
Equity
Balance as of January 1, 2018
179.7

 
$
2

 
$

 
$
2,651

 
$
(202
)
 
$
2,451

Adoption of new accounting standards

 

 

 
(31
)
 

 
(31
)
Shares issued under employee stock-based compensation plans and other
0.5

 

 

 

 

 

Net income

 

 

 
159

 

 
159

Other comprehensive income

 

 

 

 
19

 
19

Dividends declared, $0.58 per share

 

 
1

 
(106
)
 

 
(105
)
Deemed capital contribution from former shareholders of Bai Brands LLC

 

 
2

 

 

 
2

Stock options exercised and stock-based compensation

 

 
(3
)
 
(6
)
 

 
(9
)
Balance as of March 31, 2018
180.2

 
$
2

 
$

 
$
2,667

 
$
(183
)
 
$
2,486

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 

5

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1.
General
References in this Quarterly Report on Form 10-Q to "DPS" or "the Company" refer to Dr Pepper Snapple Group, Inc. and all entities included in the unaudited condensed consolidated financial statements.
This Quarterly Report on Form 10-Q refers to some of DPS' owned or licensed trademarks, trade names and service marks, which are referred to as the Company's brands. All of the product names included herein are either DPS' registered trademarks or those of the Company's licensors.
BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting principally of normal recurring adjustments, considered necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and the notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 ("Annual Report").
PRINCIPLES OF CONSOLIDATION
DPS consolidates all wholly owned subsidiaries. The Company uses the equity method to account for investments in companies if the investment provides the Company with the ability to exercise significant influence over operating and financial policies of the investee. Consolidated net income includes DPS' proportionate share of the net income or loss of these companies. Judgment regarding the level of influence over each equity method investment includes considering key factors such as ownership interest, representation on the board of directors or similar governing body, participation in policy-making decisions and material intercompany transactions.
The Company is also required to consolidate entities that are variable interest entities (“VIEs”) of which DPS is the primary beneficiary. Judgments are made in assessing whether the Company is the primary beneficiary, including determination of the activities that most significantly impact the VIE’s economic performance.
The Company eliminates from its financial results all intercompany transactions between entities included in the unaudited condensed consolidated financial statements and the intercompany transactions with its equity method investees.
USE OF ESTIMATES
The process of preparing DPS' unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amount of assets, liabilities, revenue and expenses. These estimates and judgments are based on historical experience, future expectations and other factors and assumptions the Company believes to be reasonable under the circumstances. These estimates and judgments are reviewed on an ongoing basis and are revised when necessary. Changes in estimates are recorded in the period of change. Actual amounts may differ from these estimates.
FAIR VALUE
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Based upon the transparency of inputs to the valuation of an asset or liability, a three-level hierarchy has been established for fair value measurements. The three-level hierarchy for disclosure of fair value measurements is as follows:
Level 1 - Quoted market prices in active markets for identical assets or liabilities.
Level 2 - Observable inputs such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
Level 3 - Valuations with one or more unobservable significant inputs that reflect the reporting entity's own assumptions.
The fair value of senior unsecured notes and marketable securities as of March 31, 2018 and December 31, 2017 are based on quoted market prices for publicly traded securities.

6

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


The Company estimates fair values of financial instruments measured at fair value in the financial statements on a recurring basis to ensure they are calculated based on market rates to settle the instruments. These values represent the estimated amounts DPS would pay or receive to terminate agreements, taking into consideration current market rates and creditworthiness.
As of March 31, 2018 and December 31, 2017, the Company did not have any assets or liabilities measured on a recurring basis without observable market values that would require a high level of judgment to determine fair value (Level 3).
Transfers between levels are recognized at the end of each reporting period. There were no transfers of financial instruments between the three levels of fair value hierarchy during the three months ended March 31, 2018 and 2017.
Refer to Notes 6, 7, 12 and 13 for additional information.
RECLASSIFICATIONS
Pension and other post-retirement benefit plan expenses of $1 million were reclassified from selling, general & administrative ("SG&A") expenses to other income, net, for the three months ended March 31, 2017, as a result of the retrospective adoption of Accounting Standard Update ("ASU") 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"). Refer to Recently Adopted Provisions of U.S. GAAP below.
RECENTLY ISSUED ACCOUNTING STANDARDS

Effective in 2019
In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases (Topic 842) ("ASU 2016-02"). The ASU replaces the prior lease accounting guidance in its entirety. The underlying principle of the new standard is the recognition of lease assets and lease liabilities by lessees for substantially all leases, with an exception for leases with terms of less than twelve months. The standard also requires additional quantitative and qualitative disclosures. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842) - Land Easement Practical Expedient for Transition to Topic 842, which provides an optional transition practical expedient that allows companies to not evaluate (under Topic 842) existing or expired land easements that were not previously accounted for as leases (under Topic 840).
Topic 842 is effective for interim and annual reporting periods beginning after December 15, 2018, and early adoption is permitted. Topic 842 requires a modified retrospective approach, which includes several optional practical expedients. The Company intends to adopt the standard during the quarter ending March 31, 2019. The Company has assembled a cross functional project management team, selected a software provider and has begun the implementation of the software. The Company anticipates the impact of Topic 842 will be significant to its Consolidated Balance Sheet due to the amount of the Company's lease commitments.
In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities ("ASU 2017-12"). The objective of the ASU is to improve the financial reporting of hedging relationships in order to better portray the economic results of an entity’s risk management activities in its financial statements and to make certain targeted improvements to simplify the application of hedge accounting guidance. ASU 2017-12 is effective for interim and annual reporting periods beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of ASU 2017-12 on the Company's consolidated financial statements.
In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) ("ASU 2018-02"). The objective of the ASU is to allow a reclassification from accumulated comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act ("TCJA") and will improve the usefulness of information reported to financial statement users. ASU 2018-02 is effective for interim and annual reporting periods beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of ASU 2018-02 on the Company's consolidated financial statements.

7

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


RECENTLY ADOPTED PROVISIONS OF U.S. GAAP
As of January 1, 2018, the Company adopted Revenue from Contracts with Customers (Topic 606) ("ASC 606"). The new guidance sets forth a new five-step revenue recognition model which replaces the prior revenue recognition guidance in its entirety and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the new standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance. The Company adopted the standard using the modified retrospective method and recognized the cumulative effect of initially applying the standard, which was primarily driven by the acceleration of certain customer incentives, as a $35 million reduction to the opening balance of retained earnings. The Company expects that the impact to net income of the new standard will be immaterial on an ongoing annual basis; however, the Company does anticipate that the new standard will have an impact on its net sales in interim periods due to timing. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Refer to Note 3 for additional information regarding the Company's adoption of ASC 606.
As of January 1, 2018, the Company adopted ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory ("ASU 2016-16"). ASU 2016-16 requires entities to recognize the income tax consequences of intra-entity transfers of assets other than inventories when such transfers occur. The ASU was adopted on a modified retrospective basis through a cumulative-effect adjustment, which resulted in an increase to the opening balance of retained earnings of approximately $4 million as of January 1, 2018.
As a result of the adoption of ASC 606 and ASU 2016-16, retained earnings decreased approximately $31 million as of January 1, 2018.
As of January 1, 2018, the Company adopted ASU 2017-07, which requires employers who offer defined benefit pension plans or other post-retirement benefit plans to report the service cost component within the same income statement caption as other compensation costs arising from services rendered by employees during the period. The ASU also requires the other components of net periodic benefit cost to be presented separately from the service cost component, in a caption outside of a subtotal of income from operations. Additionally, the ASU provides that only the service cost component is eligible for capitalization. As a result of the adoption, the Company reclassified $1 million from selling, general and administrative expenses to other non-operating expense, net for the three months ended March 31, 2017.
As of January 1, 2018, the Company adopted ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"), which makes several targeted improvements to U.S. GAAP. Among other things, ASU 2016-01 eliminates the cost method of accounting and investments in equity securities which were previously accounted for under the cost method must now be measured at fair value, with changes in fair value recognized in net income, under guidance in the newly added Topic 321, Investments - Equity Securities, to the Accounting Standards Codification. Equity instruments that do not have readily determinable fair values may be measured at cost less impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company also adopted ASU 2018-03, Technical Corrections and Improvements to Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which provides clarification on certain guidance issued under ASU 2016-01. The Company holds two investments in equity securities which were accounted for under the cost method of accounting prior to January 1, 2018, which do not have readily determinable fair values. The adoption of these standards did not have a material impact on such investments or the Company's consolidated financial statements.
2. Acquisitions and Investments in Unconsolidated Subsidiaries
ANNOUNCEMENT OF PROPOSED MERGER WITH MAPLE PARENT HOLDINGS CORP.
On January 29, 2018, DPS entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among DPS, Maple Parent Holdings Corp. (“Maple”) and Salt Merger Sub, Inc., a wholly-owned subsidiary of DPS (“Merger Sub”), whereby Merger Sub will be merged with and into Maple, with Maple surviving the merger as a wholly-owned subsidiary of the Company (the “Maple Merger”). For financial reporting and accounting purposes, Maple will be the acquirer of DPS upon completion of the Maple Merger.
Maple is the indirect parent of Keurig Green Mountain, Inc. ("Keurig"), through which Maple conducts all of its operations. Keurig is a leading producer of specialty coffee and innovative single serve brewing systems. The combined businesses will create Keurig Dr Pepper Inc., a new beverage company of scale with a portfolio of iconic consumer brands and expanded distribution capability to reach virtually every point-of-sale in North America.

8

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


In consideration for the Maple Merger, each share of common stock of Maple issued and outstanding immediately prior to the closing of the Maple Merger (the “Effective Time”) shall be converted into the right to receive a number of fully paid and nonassessable shares of common stock of DPS determined pursuant to an exchange ratio set forth in the Merger Agreement (the “Acquisition Shares”).
The Merger Agreement provides that DPS will declare a special cash dividend equal to $103.75 per share, subject to any withholding of taxes required by law, payable to holders of its common stock as of the record date for the special dividend, which shall be the business day immediately prior to the completion of the Maple Merger (such special dividend, together with the Maple Merger, the "Maple Transaction").
As a result of the Maple Transaction, the equityholders of Maple as of immediately prior to the Effective Time will own approximately 87% of DPS' common stock following the closing and the stockholders of DPS as of immediately prior to the Effective Time will own approximately 13% on a fully diluted basis.
The completion of the Maple Transaction requires the approval of the holders of DPS' common stock of (i) an amendment to DPS’ certificate of incorporation to increase the number of authorized shares of common stock and to change DPS' name to "Keurig Dr Pepper Inc." and (ii) the issuance of the Acquisition Shares pursuant to the Merger Agreement (collectively, the "Stockholder Approvals").
In addition to the Stockholder Approvals, the completion of the Maple Transaction will depend upon a number of conditions being satisfied or waived, including, among others, obtaining all required regulatory approvals, authorization of the listing on the New York Stock Exchange of the Acquisition Shares, the absence of any injunction prohibiting the consummation of the Maple Transaction and absence of any legal requirements enacted by any court or other governmental entity since the date of the Merger Agreement that remain in effect prohibiting consummation of the Maple Transaction. The obligation of each party to consummate the Maple Transaction is also conditioned on the other party’s representations and warranties being true and correct (subject to certain materiality exceptions) and the other party having performed in all material respects its obligations under the Merger Agreement.
The Merger Agreement may be terminated at any time prior to the Effective Time, whether before or after receipt of the Stockholder Approvals or the effectiveness of the Maple stockholder consent or Merger Sub stockholder consent, by the mutual written consent of the parties, by either Maple or DPS if the closing of the Maple Transaction does not occur by October 29, 2018 or the Stockholder Approvals are not obtained or a final and nonappealable government order prohibiting the closing of the Maple Transaction is in place, or by Maple or DPS in connection with certain breaches of the Merger Agreement by DPS or Maple, respectively.
If the Merger Agreement is terminated by DPS as a result of DPS accepting a superior proposal and entering into an alternative acquisition agreement, by Maple if our Board changes its recommendation to stockholders to approve the Stockholder Approvals or fails to reaffirm such recommendation following receipt or public announcement of a competing acquisition proposal within five business days after Maple's request to do so, or by either DPS or Maple because the closing does not occur by October 29, 2018 and there is an acquisition proposal outstanding at the time of such termination and within twelve months of termination of the Merger Agreement DPS consummates or enters into an agreement with respect to an acquisition proposal, DPS shall pay to Maple a termination fee in the amount of $700 million. If the Merger Agreement is terminated by DPS because Maple is unable to obtain required financing on the terms required by the Merger Agreement, Maple shall pay to DPS a reverse termination fee in the amount of $700 million.
Upon completion of the Maple Transaction:
all unvested stock options, restricted stock units ("RSUs") and performance share units ("PSUs") will vest immediately as a result of the Change in Control (as defined in the terms of each individual award agreement); and
the $500 million revolving line of credit (the "Revolver") will be terminated as a result of the Change in Control (as defined in the Company's unsecured credit agreement (the "Credit Agreement").
The Company has an agreement with a financial advisor in relation to the pending Maple Transaction. The Company agreed to pay a fee of approximately $50 million, $5 million of which was for the delivery of the fairness opinion during the first quarter of 2018, and the remaining portion of which will be paid upon, and subject to, consummation of the Maple Transaction.

9

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


BAI BRANDS MERGER UPDATE
On January 31, 2018, the purchase price allocation for the merger with Bai Brands LLC ("Bai Brands") ("Bai Brands Merger") was finalized. There were no changes from the preliminary purchase price allocation as of December 31, 2017, as disclosed in our Annual Report.
In February 2018, the arbitration between the Company and the former shareholders of Bai Brands was completed and the working capital adjustment, which was agreed upon during the year ended December 31, 2017, was released from restricted cash. The remaining non-current restricted cash and corresponding non-current holdback liability, net of any claims, are anticipated to be released approximately four years after the acquisition date, subject to certain administrative conditions and resolution of certain indemnification obligations.
The following table provides a rollforward of the holdback placed in escrow from December 31, 2017 to March 31, 2018:
(in millions)
 
Indemnification Escrow
 
Unrecognized Compensation Costs
 
Total Holdback Liability
Balance as of December 31, 2017
 
$
79

 
$
7

 
$
86

Recognized compensation costs
 

 
(2
)
 
(2
)
Balance as of March 31, 2018
 
$
79

 
$
5

 
$
84

TRANSACTION AND INTEGRATION EXPENSES
The following table provides information about the Company's transaction and integration expenses incurred during the three months ended March 31, 2018 and 2017:
 
 
For the Three Months Ended March 31,
(in millions)
 
2018
 
2017
Maple Transaction
 
$
12

 
$

Bai Brands Merger
 
1

 
19

Total transaction and integration expenses incurred
 
$
13

 
$
19

INVESTMENTS IN UNCONSOLIDATED SUBSIDIARIES
On January 5, 2018, the Company acquired a 5.1% interest in Core Nutrition, LLC ("Core") for $18 million. The investment is accounted for as an equity method investment as the Company is deemed to have the ability to exercise significant influence through a more than minor interest in the investee in accordance with U.S. GAAP.
3. Revenues
The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Branded product sales, which include carbonated soft drinks ("CSDs"), non-carbonated beverages ("NCBs") and allied brand sales, occur once control is transferred upon delivery to the customer's facility. Contract manufacturing sales occur once control is transferred, either upon shipment or at the time the finished goods are ready for shipment and billed to the customer, based upon the terms of the contract with the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Sales taxes and other similar taxes are excluded from revenue. Costs associated with shipping and handling activities, such as merchandising, are included in SG&A expenses as revenue is recognized.
The Company entered into arrangements during 2010 to license the manufacturing and distribution of certain brands to PepsiCo, Inc. ("PepsiCo") and The Coca-Cola Company ("Coca-Cola") and to sell and deliver all concentrates used in the manufacture of licensed beverages under these arrangements as PepsiCo and Coca-Cola place orders for these concentrates. In these cases, the Company first determined whether the arrangements represented separate performance obligations. The primary requirements to meet the separate performance obligation criteria is whether the performance obligation is capable of being distinct and distinct in the context of the contract. As the sale of the manufacturing and distribution rights and the ongoing sales of concentrate would not have economic benefit to the customer on its own or together with other resources that are available to the customer and the promises are not capable of being distinct, only one performance obligation was identified for these arrangements. The one-time nonrefundable cash receipts from PepsiCo and Coca-Cola were therefore recorded as deferred revenue and are recognized as net sales ratably over time during the estimated 25-year life of the customer relationship.

10

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


The adoption of ASC 606 resulted in an immaterial impact to the individual financial statement line items of the Company's unaudited Condensed Consolidated Statements of Income during the three months ended March 31, 2018.
For the three months ended March 31, 2018, the Company recognized $16 million of net sales that were included in deferred revenue at the beginning of the respective periods, which relates to the PepsiCo and Coca-Cola arrangements primarily within the Beverage Concentrates operating segment.
Information about the Company's net sales by reporting segment and portfolio for the three months ended March 31, 2018 and 2017 is as follows:
(in millions)
Beverage Concentrates
 
Packaged Beverages
 
Latin America Beverages
 
Total
For the three months ended March 31, 2018:
 
 
 
 
 
 
 
Carbonated soft drinks ("CSDs")(1)
$
280

 
$
477

 
$
76

 
$
833

Non-carbonated beverages ("NCBs")(2)
3

 
477

 
36

 
516

Contract manufacturing(3)

 
69

 
1

 
70

Allied brand sales(4)


 
147

 

 
147

Other(5)
20

 
8

 

 
28

Net sales
$
303

 
$
1,178

 
$
113

 
$
1,594

 
 
 
 
 
 
 
 
For the three months ended March 31, 2017:(6)
 
 
 
 
 
 
 
CSDs(1)
$
271

 
$
462

 
$
66

 
$
799

NCBs(2)
3

 
449

 
32

 
484

Contract manufacturing(3)

 
60

 

 
60

Allied brand sales(4)


 
139

 

 
139

Other(5)
20

 
8

 

 
28

Net sales
$
294

 
$
1,118

 
$
98

 
$
1,510

__________________
(1)
Represents product sales of owned CSD brands within our portfolio and the net sales recognized ratably under the PepsiCo and Coca-Cola arrangements. Product sales include the sale of beverage concentrates, syrup and packaged beverages.
(2)
Represents product sales of owned NCB brands within our portfolio. Product sales primarily include packaged beverages.
(3)
Net sales from contract manufacturing, bottling beverages and other products for private label owners or others.
(4)
Allied brand sales represent product distribution of third party brands.
(5)
Other sales include miscellaneous revenues, such as royalties.
(6)
Prior period amounts were not adjusted for the adoption of the new revenue recognition guidance under ASC 606.
Information about the Company's net sales by reporting segment and geography for the three months ended March 31, 2018 and 2017 is as follows:
(in millions)
Beverage Concentrates
 
Packaged Beverages
 
Latin America Beverages
 
Total
For the three months ended March 31, 2018:
 
 
 
 
 
 
 
United States ("U.S.")
$
284

 
$
1,146

 
$

 
$
1,430

Canada
19

 
32

 

 
51

Latin America and other(1)

 

 
113

 
113

Net sales
$
303

 
$
1,178

 
$
113

 
$
1,594

 
 
 
 
 
 
 
 
For the three months ended March 31, 2017:(2)
 
 
 
 
 
 
 
U.S.
$
277

 
$
1,089

 
$

 
$
1,366

Canada
17

 
29

 

 
46

Latin America and other(1)

 

 
98

 
98

Net sales
$
294

 
$
1,118

 
$
98

 
$
1,510

__________________
(1)
Other includes immaterial net sales in geographical locations outside of U.S., Latin America and Canada.
(2)
Prior period amounts were not adjusted for the adoption of the new revenue recognition guidance under ASC 606.

11

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


4.
Goodwill and Other Intangible Assets
CHANGE IN THE COMPANY'S OPERATING SEGMENTS AND REPORTING UNITS
As of January 1, 2018, due to changes to the information reviewed by the chief operating decision maker and limited availability of discrete financial information, the Company has determined that Bai no longer meets the criteria to be considered an operating segment. Therefore, as of January 1, 2018, the Company has three operating segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages. There is no change to the Company's reportable segments, as previously Bai and Packaged Beverages Excluding Bai were aggregated into the Packaged Beverages reportable segment.
The Company has additionally concluded that Bai meets the criteria to be considered a component of the Packaged Beverages segment. However, as the economic characteristics of Bai and Warehouse Direct ("WD") are similar, the Company has aggregated Bai and WD into a single reporting unit as of January 1, 2018.
GOODWILL
Changes in the carrying amount of goodwill by reporting unit are as follows:
(in millions)
Beverage Concentrates
 
WD Reporting Unit(1)
 
DSD Reporting Unit(1)
 
Bai(1)
 
Latin America Beverages
 
Total
Balance as of December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
Goodwill
$
1,733

 
$
1,222

 
$
189

 
$
568

 
$
29

 
$
3,741

Accumulated impairment losses

 

 
(180
)
 

 

 
(180
)
 
1,733

 
1,222

 
9

 
568

 
29

 
3,561

Foreign currency impact

 

 

 

 
3

 
3

Reclassifications(2)

 
568

 

 
(568
)
 

 

Balance as of March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
Goodwill
1,733

 
1,790

 
189

 

 
32

 
3,744

Accumulated impairment losses

 

 
(180
)
 

 

 
(180
)
 
$
1,733

 
$
1,790

 
$
9

 
$

 
$
32

 
$
3,564

____________________________
(1)
As of January 1, 2018, the Packaged Beverages operating segment is comprised of three reporting units, the Direct Store Delivery ("DSD") system, WD and Bai.
(2)
As of January 1, 2018, due to changes in the Company's operating segments and reporting units, the goodwill associated with the Bai operating segment was reclassified to the WD reporting unit. Refer to Change in the Company's Operating Segments and Reporting Units above.

12

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


INTANGIBLE ASSETS OTHER THAN GOODWILL
The net carrying amounts of intangible assets other than goodwill are as follows:
 
March 31, 2018
 
December 31, 2017
 
Gross
 
Accumulated
 
Net
 
Gross
 
Accumulated
 
Net
(in millions)
Amount
 
Amortization
 
Amount
 
Amount
 
Amortization
 
Amount
Intangible assets with indefinite lives:
 
 
 
 
 
 
 
 
 
 
 
Brands(1)
$
3,697

 
 
 
$
3,697

 
$
3,694

 
 
 
$
3,694

Distribution rights
32

 
 
 
32

 
32

 
 
 
32

Intangible assets with definite lives:
 
 
 
 
 
 
 
 
 
 
 
Customer relationships
106

 
$
(80
)
 
26

 
106

 
$
(79
)
 
27

Non-compete agreements
22

 
(3
)
 
19

 
22

 
(2
)
 
20

Distribution rights
21

 
(11
)
 
10

 
18

 
(10
)
 
8

Brands
29

 
(29
)
 

 
29

 
(29
)
 

Bottler agreements
19

 
(19
)
 

 
19

 
(19
)
 

Total
$
3,926

 
$
(142
)
 
$
3,784

 
$
3,920

 
$
(139
)
 
$
3,781

____________________________
(1)
Indefinite lived brand assets increased $3 million as a result of foreign currency translation.
Amortization expense for intangible assets with definite lives for the three months ended March 31, 2018 and 2017 was $3 million and $2 million, respectively.
Amortization expense of these intangible assets over the remainder of 2018 and the next four years is expected to be as follows:
 
Remainder of 2018
 
For the Years Ended December 31,
(in millions)
 
2019
 
2020
 
2021
 
2022
Projected amortization expense for intangible assets with definite lives
$
13

 
$
14

 
$
9

 
$
7

 
$
5

IMPAIRMENT TESTING
The Company conducts impairment tests on goodwill and all indefinite lived intangible assets annually or more frequently if circumstances indicate that the carrying amount of an asset may not be recoverable. DPS did not identify any circumstances that indicated that the carrying amount of any goodwill or any indefinite lived intangible asset may not be recoverable as of March 31, 2018.
5. Income Taxes
The legislation commonly referred to as the Tax Cuts and Jobs Act (the "TCJA") was enacted on December 22, 2017. The TCJA reduced the U.S. federal statutory tax rate from 35% to 21% effective January 1, 2018, repealed the domestic manufacturing deduction effective January 1, 2018 and made changes to the international tax rules.

13

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


The effective tax rates for the three months ended March 31, 2018 and 2017 were 24.7% and 28.6%, respectively. The following is a reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate to the provision for income taxes reported in the unaudited Condensed Consolidated Statements of Income:
 
For the Three Months Ended March 31, 2018
 
For the Three Months Ended March 31, 2017
(in millions)
Amount
 
Percentage
 
Amount
 
Percentage
 Statutory federal income tax(1)
$
46

 
21.0
 %
 
$
87

 
35.0
 %
 State income taxes, net(2)
10

 
4.6
 %
 
8

 
3.2
 %
 US federal domestic manufacturing benefit(3)

 
 %
 
(6
)
 
(2.4
)%
 Impact of non-US operations(4)
1

 
0.5
 %
 
(1
)
 
(0.4
)%
 Stock-based compensation benefit(5)
(5
)
 
(2.3
)%
 
(18
)
 
(7.3
)%
 Other
2

 
0.9
 %
 
1

 
0.5
 %
 Total income tax provision
$
54

 
24.7
 %
 
$
71

 
28.6
 %
____________________________
For the three months ended March 31, 2018, the TCJA
(1)
reduced the U.S. federal statutory tax rate from 35% to 21%.
(2)
decreased the federal income tax benefit from the deduction of state income taxes from 35% to 21%.
(3)
repealed the U.S. federal domestic manufacturing deduction.
(4)
caused the impact of non-U.S. operations to switch from an income tax benefit to an income tax detriment due to the lower U.S. federal statutory tax rate.
(5)
reduced the tax benefit from stock-based compensation due to the lower U.S. federal statutory tax rate; additionally, the pre-tax windfall in the current period was less than the prior period.
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin (“SAB”) 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which provides guidance on accounting for the impact of the TCJA, in effect allowing an entity to use a methodology similar to the measurement period in a business combination for tax impacts effective in the fourth quarter of 2017. Pursuant to the provisions of SAB 118, as of March 31, 2018, the Company has not completed its accounting for the tax effects of the TCJA. The Company recorded a reasonable estimate of the impact from the TCJA, but is still analyzing the TCJA and refining our calculations. Additionally, future guidance from the Internal Revenue Service, SEC, or the FASB could result in changes to our accounting for the tax effects of the TCJA.
6.
Long-term Obligations and Borrowing Arrangements
The following table summarizes the Company's long-term obligations:
 
March 31,
 
December 31,
(in millions)
2018
 
2017
Senior unsecured notes
$
4,212

 
$
4,230

Capital lease obligations
186

 
183

Subtotal
4,398

 
4,413

Less - current portion
(263
)
 
(13
)
Long-term obligations
$
4,135

 
$
4,400

The following table summarizes the Company's short-term borrowings and current portion of long-term obligations:
 
Fair Value Hierarchy Level
 
March 31, 2018
 
December 31, 2017
(in millions)
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Commercial paper
1
 
$
120

 
$
120

 
$
66

 
$
66

Current portion of long-term obligations:
 
 
 
 
 
 
 
 
 
Senior unsecured notes
2
 
249

 
249

 

 

Capital lease obligations(1)
N/A
 
14

 
 
 
13

 
 
Short-term borrowings and current portion of long-term obligations
 
 
$
383

 
$
369

 
$
79

 
$
66

____________________________
(1)
Capital lease obligations are specifically excluded from the calculation of fair value under U.S. GAAP.

14

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


SENIOR UNSECURED NOTES 
The Company's senior unsecured notes (collectively, the "Notes") consisted of the following carrying values and estimated fair values that are not required to be measured at fair value in the Consolidated Balance Sheets are as follows:
(in millions)
 
 
 
 
 
Fair Value Hierarchy Level
 
March 31, 2018
 
December 31, 2017
Issuance
 
Maturity Date
 
Rate
 
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
2019 Notes
 
January 15, 2019
 
2.60%
 
2
 
$
250

 
$
249

 
$
250

 
$
251

2020 Notes
 
January 15, 2020
 
2.00%
 
2
 
250

 
245

 
250

 
248

2021-A Notes
 
November 15, 2021
 
3.20%
 
2
 
250

 
247

 
250

 
255

2021-B Notes
 
November 15, 2021
 
2.53%
 
2
 
250

 
242

 
250

 
249

2022 Notes
 
November 15, 2022
 
2.70%
 
2
 
250

 
239

 
250

 
248

2023 Notes
 
December 15, 2023
 
3.13%
 
2
 
500

 
481

 
500

 
504

2025 Notes
 
November 15, 2025
 
3.40%
 
2
 
500

 
477

 
500

 
508

2026 Notes
 
September 15, 2026
 
2.55%
 
2
 
400

 
354

 
400

 
378

2027 Notes
 
June 15, 2027
 
3.43%
 
2
 
500

 
470

 
500

 
501

2038 Notes
 
May 1, 2038
 
7.45%
 
2
 
125

 
174

 
125

 
179

2045 Notes
 
November 15, 2045
 
4.50%
 
2
 
550

 
528

 
550

 
588

2046 Notes
 
December 15, 2046
 
4.42%
 
2
 
400

 
379

 
400

 
424

Principal amount
 
 
 
 
 
 
 
$
4,225

 
$
4,085

 
$
4,225

 
$
4,333

Unamortized premiums, discounts, and debt issuance costs
 
 
 
(12
)
 
 
 
(13
)
 
 
Adjustments to carrying value for interest rate swaps(1)
 
 
 
(1
)
 
 
 
18

 
 
Carrying amount
 
 
 
 
 
 
 
$
4,212

 
 
 
$
4,230

 
 
____________________________
(1)
Refer to Note 7 for additional information on the Company's interest rate swaps.
The indentures governing the Notes, among other things, limit the Company's ability to incur indebtedness secured by principal properties, to enter into certain sale and leaseback transactions and to enter into certain mergers or transfers of substantially all of DPS' assets. The Notes are guaranteed by all of the Company's existing and future direct and indirect subsidiaries that guarantee any of the Company's other indebtedness. As of March 31, 2018, the Company was in compliance with all financial covenant requirements of the Notes.
The fair value amounts of long term debt were based on current market rates available to the Company. The difference between the fair value and the carrying value represents the theoretical net premium or discount that would be paid or received to retire all debt and related unamortized costs to be incurred at such date. The carrying amount includes the unamortized discounts and issuance costs on the issuance of debt and impact of interest rate swaps designated as fair value hedges and other hedge related adjustments. Refer to Note 7 for additional information regarding the notes subject to fair value hedges. 
BORROWING ARRANGEMENTS
Commercial Paper Program
The following table provides information about the Company's weighted average borrowings under its commercial paper program for the three months ended March 31, 2018 and 2017:
 
 
For the Three Months Ended
 
 
March 31,
(in millions, except percentages)
 
2018
 
2017
Weighted average commercial paper borrowings(1)
 
$
115

 
$
6

Weighted average borrowing rates
 
1.95
%
 
1.03
%
____________________________
(1)
Borrowings during the period had maturities of 90 days or less.
Upon execution of the Merger Agreement on January 29, 2018, the Company became limited to a maximum aggregate amount of commercial paper outstanding of $200 million, unless it obtains Maple's approval. Refer to Note 2 for additional information about the Merger Agreement.

15

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


Unsecured Credit Agreement
The following table provides amounts utilized and available under the "Revolver" as of March 31, 2018:
(in millions)
Amount Utilized
 
Balances Available
Revolver
$

 
$
380

Letters of credit

 
75

As of March 31, 2018, the Company was in compliance with all financial covenant requirements relating to the Credit Agreement.
Shelf Registration Statement
The Company filed a "well-known seasoned issuer" shelf registration statement with the SEC, effective September 2, 2016, which registered an indeterminate amount of securities for future sales. The Company's Board of Directors (the "Board") authorizes the amount of securities that the Company may issue. As of March 31, 2018, $450 million remained authorized to be issued under the Board's authorization.
Letters of Credit Facilities
In addition to the portion of the Revolver reserved for issuance of letters of credit, the Company has incremental letters of credit facilities. Under these facilities, $120 million is available for the issuance of letters of credit, $60 million of which was utilized as of March 31, 2018 and $60 million of which remains available for use.
7. Derivatives
DPS is exposed to market risks arising from adverse changes in:
interest rates;
foreign exchange ("FX") rates; and
commodity prices affecting the cost of raw materials and fuels.
The Company manages these risks through a variety of strategies, including the use of interest rate contracts, FX forward contracts, commodity forward and future contracts and supplier pricing agreements. DPS does not hold or issue derivative financial instruments for trading or speculative purposes.
The Company formally designates and accounts for certain interest rate contracts and foreign exchange forward contracts that meet established accounting criteria under U.S. GAAP as either fair value or cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative instruments is recorded, net of applicable taxes, in Accumulated Other Comprehensive Loss ("AOCL"), a component of Stockholders' Equity in the unaudited Condensed Consolidated Balance Sheets. When net income is affected by the variability of the underlying transaction, the applicable offsetting amount of the gain or loss from the derivative instrument deferred in AOCL is reclassified to net income and is reported as a component of the unaudited Condensed Consolidated Statements of Income. For derivative instruments that are designated and qualify as fair value hedges, the effective change in the fair value of the instrument, as well as the offsetting gain or loss on the hedged item attributable to the hedged risk, are recognized immediately in current-period earnings. For derivatives that are not designated or are de-designated as a hedging instrument, the gain or loss on the instrument is recognized in earnings in the period of change. Cash flows from derivative instruments designated in a qualifying hedging relationship are classified in the same category as the cash flows from the hedged items.
Certain interest rate contracts qualify for the "shortcut" method of accounting for hedges under U.S. GAAP. Under the shortcut method, the hedges are assumed to be perfectly effective and no ineffectiveness is recorded in earnings. For all other designated hedges, the Company assesses whether the derivative instrument is effective in offsetting the changes in fair value or variability of cash flows at the inception of the derivative contract. DPS measures hedge ineffectiveness on a quarterly basis throughout the designated period. Changes in the fair value of the derivative instrument that do not effectively offset changes in the fair value of the underlying hedged item throughout the designated hedge period are recorded in earnings each period.
If a fair value or cash flow hedge were to cease to qualify for hedge accounting, or were terminated, the derivatives would continue to be carried on the balance sheet at fair value until settled and hedge accounting would be discontinued prospectively. If the underlying hedged transaction ceases to exist, any associated amounts reported in AOCL would be reclassified to earnings at that time.

16

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


INTEREST RATES 
Fair Value Hedges
The Company is exposed to the risk of changes in the fair value of certain fixed-rate debt attributable to changes in interest rates and manages these risks through the use of receive-fixed, pay-variable interest rate swaps. Any ineffectiveness is recorded as interest during the period incurred. The following table presents information regarding these interest rate swaps and the associated hedging relationships:
 
 
 
 
 
 
 
 
Impact to the carrying value
($ in millions)
 
 
 
 
 
Method of
 
 
 
of long-term debt
 
 
Hedging
 
Number of
 
measuring
 
Notional
 
March 31,
 
December 31,
Period entered
 
relationship
 
instruments
 
effectiveness
 
value
 
2018
 
2017
November 2011
 
2019 Notes
 
2
 
Short cut method
 
$
100

 
$
(1
)
 
$

November 2011
 
2021-A Notes
 
2
 
Short cut method
 
150

 
(3
)
 
(1
)
November 2012
 
2020 Notes
 
5
 
Short cut method
 
120

 
(3
)
 
(2
)
December 2016
 
2021-B Notes
 
2
 
Short cut method
 
250

 
(7
)
 
(4
)
December 2016
 
2023 Notes
 
2
 
Short cut method
 
150

 
(6
)
 
(3
)
January 2017
 
2022 Notes
 
4
 
Regression
 
250

 
8

 
17

June 2017
 
2038 Notes
 
1
 
Regression
 
50

 
11

 
11

 
 
 
 
 
 
 
 
$
1,070

 
$
(1
)
 
$
18

FOREIGN EXCHANGE
Cash Flow Hedges
The Company's Canadian and Mexican businesses purchase certain inventory through transactions denominated and settled in United States ("U.S.") dollars, a currency different from the functional currency of those businesses. These inventory purchases are subject to exposure from movements in exchange rates. During the three months ended March 31, 2018 and 2017, the Company utilized FX forward contracts designated as cash flow hedges to manage the exposures resulting from changes in these foreign currency exchange rates. The intent of these FX contracts is to provide predictability in the Company's overall cost structure. These FX contracts, carried at fair value, have maturities between one and nine months as of March 31, 2018. The Company had outstanding FX forward contracts with notional amounts of $49 million and $48 million as of March 31, 2018 and December 31, 2017, respectively.
COMMODITIES
Economic Hedges
DPS centrally manages the exposure to volatility in the prices of certain commodities used in its production process and transportation through forward and future contracts. The intent of these contracts is to provide a certain level of predictability in the Company's overall cost structure. During the three months ended March 31, 2018 and 2017, the Company held forward and future contracts that economically hedged certain of its risks. In these cases, a natural hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in the same line item of the unaudited Condensed Consolidated Statements of Income as the hedged transaction. Unrealized gains and losses are recognized as a component of unallocated corporate costs until the Company's operating segments are affected by the completion of the underlying transaction, at which time the gain or loss is reflected as a component of the respective segment's operating profit ("SOP"). The total notional values of derivatives related to economic hedges of this type were $185 million and $199 million as of March 31, 2018 and December 31, 2017, respectively.

17

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


FAIR VALUE OF DERIVATIVE INSTRUMENTS
The following table summarizes the fair value hierarchy and the location of the fair value of the Company's derivative instruments designated as hedging instruments within the unaudited Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017:
(in millions)
Fair Value Hierarchy Level
 
Balance Sheet Location
 
March 31,
2018
 
December 31,
2017
Assets:
 
 
 
 
 
 
 
Interest rate contracts
2
 
Prepaid expenses and other current assets
 
$

 
$
3

FX forward contracts
2
 
Prepaid expenses and other current assets
 

 
2

Interest rate contracts
2
 
Other non-current assets
 
12

 
16

Liabilities:
 
 
 
 
 
 
 
Interest rate contracts
2
 
Other current liabilities
 
8

 
3

FX forward contracts
2
 
Other current liabilities
 
1

 

Interest rate contracts
2
 
Other non-current liabilities
 
12

 
8

The following table summarizes the fair value hierarchy and the location of the fair value of the Company's derivative instruments not designated as hedging instruments within the unaudited Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017:
(in millions)
Fair Value Hierarchy Level
 
Balance Sheet Location
 
March 31,
2018
 
December 31,
2017
Assets:
 
 
 
 
 
 
 
Commodity contracts
2
 
Prepaid expenses and other current assets
 
$
21

 
$
27

Commodity contracts
2
 
Other non-current assets
 
12

 
17

Liabilities:
 
 
 
 
 
 
 
Commodity contracts
2
 
Other non-current liabilities
 
1

 

The fair values of commodity contracts, interest rate contracts and FX forward contracts are determined based on inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. The fair value of commodity contracts are valued using the market approach based on observable market transactions, primarily underlying commodities futures or physical index prices, at the reporting date. Interest rate contracts are valued using models based primarily on readily observable market parameters, such as LIBOR forward rates, for all substantial terms of the Company's contracts and credit risk of the counterparties. The fair value of FX forward contracts are valued using quoted forward FX prices at the reporting date. Therefore, the Company has categorized these contracts as Level 2.

18

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


IMPACT OF CASH FLOW HEDGES
The following table presents the impact of derivative instruments designated as cash flow hedging instruments under U.S. GAAP to the unaudited Condensed Consolidated Statements of Income and Comprehensive Income:
(in millions)
Amount of Loss Recognized in Other Comprehensive Loss ("OCI")
 
Amount of Loss Reclassified from AOCL into Income
 
Location of Loss Reclassified from AOCL into Income
For the three months ended March 31, 2018:
 
 
 
 
 
Interest rate contracts
$

 
$
(2
)
 
Interest expense
FX forward contracts
(1
)
 

 
Cost of sales
Total
$
(1
)
 
$
(2
)
 
 
 
 
 
 
 
 
For the three months ended March 31, 2017:
 
 
 
 
 
Interest rate contracts
$

 
$
(2
)
 
Interest expense
FX forward contracts
(5
)
 

 
Cost of sales
Total
$
(5
)
 
$
(2
)
 
 
For the three months ended March 31, 2018 and 2017, no hedge ineffectiveness was recognized in earnings with respect to derivative instruments designated as cash flow hedges. During the next 12 months, the Company expects to reclassify pre-tax net losses of $11 million from AOCL into net income.
IMPACT OF FAIR VALUE HEDGES
The following table presents the impact of derivative instruments designated as fair value hedging instruments under U.S. GAAP to the unaudited Condensed Consolidated Statements of Income:
(in millions)
 
Amount of Gain Recognized in Income
 
Location of Gain
Recognized in Income
For the three months ended March 31, 2018:
 
 
 
 
Interest rate contracts
 
$
1

 
Interest expense
 
 
 
 
 
For the three months ended March 31, 2017:
 
 
 
 
Interest rate contracts
 
$
4

 
Interest expense
For the three months ended March 31, 2018 and 2017, no hedge ineffectiveness was recognized in earnings with respect to derivative instruments designated as fair value hedges for each period.

19

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


IMPACT OF ECONOMIC HEDGES
The following table presents the impact of derivative instruments not designated as hedging instruments under U.S. GAAP to the unaudited Condensed Consolidated Statements of Income:
(in millions)
 
Amount of Gain (Loss)
Recognized in Income
 
Location of Gain (Loss)
Recognized in Income
For the three months ended March 31, 2018:
 
 
 
 
Commodity contracts(1)
 
$
(8
)
 
Cost of sales
Commodity contracts(1)
 
3

 
SG&A expenses
Total
 
$
(5
)
 
 
 
 
 
 
 
For the three months ended March 31, 2017:
 
 
 
 
Commodity contracts(1)
 
$
21

 
Cost of sales
Commodity contracts(1)
 
(13
)
 
SG&A expenses
Interest rate contracts(2)
 
1

 
Interest expense
Total
 
$
9

 
 
____________________________
(1)
Commodity contracts include both realized and unrealized gains and losses.
(2)
Represents gains on the interest rate contracts related to the 2022 Notes prior to re-designation of hedging relationship in January 2017.
The Company has exposure to credit losses from derivative instruments in an asset position in the event of nonperformance by the counterparties to the agreements. Historically, DPS has not experienced credit losses as a result of counterparty nonperformance. The Company selects and periodically reviews counterparties based on credit ratings, limits its exposure to a single counterparty under defined guidelines and monitors the market position of the programs upon execution of a hedging transaction and at least on a quarterly basis.
8. Stock-Based Compensation
The Company's Omnibus Stock Incentive Plan of 2009 ( "DPS Stock Plan") provides for various long-term incentive awards, including stock options, RSUs and PSUs.
Stock-based compensation expense is recorded in SG&A expenses in the unaudited Condensed Consolidated Statements of Income. The components of stock-based compensation expense are presented below:
 
For the Three Months Ended March 31,
(in millions)
2018
 
2017
Total stock-based compensation expense
$
10

 
$
6

Income tax benefit recognized in the Statements of Income
(2
)
 
(2
)
Stock-based compensation expense, net of tax
$
8

 
$
4


20

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


STOCK OPTIONS
The table below summarizes stock option activity for the three months ended March 31, 2018:
 
Stock Options
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value (in millions)
Outstanding as of January 1, 2018
1,372,606

 
$
82.83

 
7.86
 
$
20

Exercised
(23,510
)
 
77.15

 
 
 
1

Forfeited or expired
(3,519
)
 
93.52

 
 
 
 
Outstanding as of March 31, 2018
1,345,577

 
82.90

 
7.62
 
48

Exercisable as of March 31, 2018
938,886

 
78.19

 
7.19
 
38

As of March 31, 2018, there was $4 million of unrecognized compensation cost related to unvested stock options granted under the DPS Stock Plan that is expected to be recognized over a weighted average period of 1.26 years.
RESTRICTED STOCK UNITS    
The table below summarizes RSU activity for the three months ended March 31, 2018. The fair value of RSUs is determined based on the number of units granted and the grant date price of the Company's common stock.
 
RSUs
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value (in millions)
Outstanding as of January 1, 2018
942,124

 
$
88.44

 
0.82
 
$
91

Granted
432,538

 
116.13

 
 
 
 
Vested and released
(501,852
)
 
84.24

 
 
 
58

Forfeited
(6,745
)
 
92.86

 
 
 
 
Outstanding as of March 31, 2018
866,065

 
104.67

 
1.79
 
103

As of March 31, 2018, there was $80 million of unrecognized compensation cost related to unvested RSUs granted under the DPS Stock Plan that is expected to be recognized over a weighted average period of 1.78 years.
During the three months ended March 31, 2018, 501,852 shares subject to previously granted RSUs vested. A majority of these vested RSUs were net share settled. The Company withheld 144,882 shares based upon the Company's closing stock price on the vesting date to settle the employees' minimum statutory obligation for applicable income and other employment taxes. Subsequently, the Company remitted the required funds to the appropriate taxing authorities.
PERFORMANCE SHARE UNITS
The table below summarizes PSU activity for the three months ended March 31, 2018. The fair value of PSUs is determined based on the number of units granted and the grant date price of the Company's common stock.
 
PSUs
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value (in millions)
Outstanding as of January 1, 2018
329,490

 
$
51.69

 
0.98
 
$
32

Vested and released
(92,589
)
 
67.35

 
 
 
11

Forfeited
(21,972
)
 
67.11

 
 
 
 
Outstanding as of March 31, 2018
214,929

 
45.66

 
1.25
 
25

As of March 31, 2018, there was $6 million of unrecognized compensation cost related to unvested PSUs granted under the DPS Stock Plan that is expected to be recognized over a weighted average period of 1.25 years.

21

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


During the three months ended March 31, 2018, 92,589 units subject to previously granted PSUs vested. A majority of these vested PSUs were net share settled. The Company withheld 27,373 shares based upon the Company's closing stock price on the vesting date to settle the employees' minimum statutory obligation for the applicable income and other employment taxes. Subsequently, the Company remitted the required funds to the appropriate taxing authorities.
9. Earnings Per Share
Basic earnings per share ("EPS") is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the assumed conversion of all dilutive securities. The following table presents the basic and diluted EPS and the Company's basic and diluted shares outstanding:
 
For the Three Months Ended March 31,
(in millions, except per share data)
2018
 
2017
Basic EPS:
 
 
 
Net income
$
159

 
$
177

Weighted average common shares outstanding
179.9

 
183.4

Earnings per common share — basic
$
0.88

 
$
0.97

Diluted EPS:
 
 
 
Net income
$
159

 
$
177

Weighted average common shares outstanding
179.9

 
183.4

Effect of dilutive securities:
 
 
 
Stock options
0.3

 
0.3

RSUs
0.5

 
0.7

PSUs
0.1

 
0.2

Weighted average common shares outstanding and common stock equivalents
180.8

 
184.6

Earnings per common share — diluted
$
0.88

 
$
0.96

Stock options, RSUs, PSUs and dividend equivalent units ("DEUs") totaling 0.1 million and 0.5 million shares were excluded from the diluted weighted average shares outstanding for the three months ended March 31, 2018 and 2017, respectively, as they were not dilutive.
Under the terms of our RSU and PSU agreements, unvested RSU and PSU awards contain forfeitable rights to dividends and DEUs. Because the DEUs are forfeitable, they are defined as non-participating securities. As of March 31, 2018, there were 22,526 DEUs, which will vest at the time that the underlying RSU or PSU vests.
As of March 31, 2018, the Company's Board has authorized a total aggregate share repurchase plan of $5 billion. The Company's share repurchase program was suspended during negotiation of the Maple Transaction, and it remains suspended as of March 31, 2018 under the terms of the Merger Agreement. The Company therefore did not repurchase any shares during the three months ended March 31, 2018. The Company repurchased and retired 0.3 million shares of common stock valued at approximately $28 million for the three months ended March 31, 2017.

22

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


10. Accumulated Other Comprehensive Loss
The following tables provide a summary of changes in the balances of each component of AOCL, net of taxes:
 (in millions)
Foreign Currency Translation
 
Change in Pension Liability
 
Cash Flow Hedges
 
Accumulated Other Comprehensive Loss
Balance as of January 1, 2017
$
(164
)
 
$
(37
)
 
$
(28
)
 
$
(229
)
OCI before reclassifications
16

 
1

 
(7
)
 
10

Amounts reclassified from AOCL

 
4

 
13

 
17

Net current year OCI
16

 
5

 
6

 
27

Balance as of December 31, 2017
(148
)
 
(32
)
 
(22
)
 
(202
)
OCI before reclassifications
18

 

 
(2
)
 
16

Amounts reclassified from AOCL

 
1

 
2

 
3

Net current period OCI
18

 
1

 

 
19

Balance as of March 31, 2018
$
(130
)
 
$
(31
)
 
$
(22
)
 
$
(183
)
The following table presents the amount of loss reclassified from AOCL into the unaudited Condensed Consolidated Statements of Income:
 
 
 
For the Three Months Ended March 31,
 (in millions)
Location of Loss Reclassified
from AOCL into Income
 
2018
 
2017
Loss on cash flow hedges:
 
 
 
 
 
Interest rate contracts
Interest expense
 
$
(2
)
 
$
(2
)
Foreign exchange forward contracts
Cost of sales
 

 

Total
 
 
(2
)
 
(2
)
Income tax benefit
 
 

 
(1
)
Total
 
 
$
(2
)
 
$
(1
)
 
 
 
 
 
 
Defined benefit pension and post-retirement plan items:
 
 
 
 
 
Amortization of actuarial losses, net
Other income, net
 
$
(1
)
 
$
(1
)
Total
 
 
(1
)
 
(1
)
Income tax benefit
 
 

 

Total
 
 
$
(1
)
 
$
(1
)
 
 
 
 
 
 
Total reclassifications
 
 
$
(3
)
 
$
(2
)

23

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


11.
Inventories
Inventories consisted of the following:
 
March 31,
 
December 31,
(in millions)
2018
 
2017
Raw materials
$
79

 
$
81

Spare parts
25

 
24

Work in process
7

 
7

Finished goods
166

 
149

Inventories at first in first out cost
277

 
261

Reduction to LIFO cost
(34
)
 
(32
)
Inventories
$
243

 
$
229

Approximately $189 million and $177 million of the Company's inventory was accounted for under the LIFO method of accounting as of March 31, 2018 and December 31, 2017, respectively. The reduction to LIFO cost reflects the excess of the current cost of LIFO inventories as of March 31, 2018 and December 31, 2017, over the amount at which these inventories were valued on the unaudited Condensed Consolidated Balance Sheets. For the three months ended March 31, 2018 and 2017, there was no LIFO inventory liquidation.

24

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


12. Other Assets and Liabilities
The table below details the components of other assets and other liabilities:
 
March 31,
 
December 31,
(in millions)
2018
 
2017
Prepaid expenses and other current assets:
 
 
 
Customer incentive programs
$
118

 
$
16

Derivative instruments
21

 
32

Prepaid income taxes
9

 
7

Other
77

 
44

Total prepaid expenses and other current assets
$
225

 
$
99

Other non-current assets:
 
 
 
Customer incentive programs
$
77

 
$
76

Marketable securities - trading(1)
52

 
48

Derivative instruments
24

 
33

Equity securities without readily determinable fair values
1

 
1

Non-current restricted cash and restricted cash equivalents
92

 
79

Other
40

 
42

Total other non-current assets
$
286

 
$
279

 
 
 
 
Other current liabilities:
 
 
 
Customer rebates and incentives
$
345

 
$
299

Accrued compensation
81

 
130

Insurance liability
36

 
34

Interest accrual
46

 
20

Dividends payable
105

 
103

Derivative instruments
9

 
3

Holdback liability to former Bai Brands shareholders
5

 
7

Acquired contingent liabilities
11

 
14

Other
123

 
109

Total other current liabilities
$
761

 
$
719

Other non-current liabilities:
 
 
 
Long-term payables due to Mondelēz International, Inc.
$
16

 
$
16

Long-term pension and post-retirement liability
20

 
19

Insurance liability
60

 
60

Derivative instruments
13

 
8

Deferred compensation liability
52

 
48

Holdback liability to former Bai Brands shareholders
79

 
79

Acquired contingent liabilities
5

 
5

Other
28

 
29

Total other non-current liabilities
$
273

 
$
264

____________________________
(1)
Fair values of marketable securities are determined using quoted market prices from daily exchange traded markets, based on the closing price as of the balance sheet date, and are classified as Level 1. The fair value of marketable securities was $52 million and $48 million as of March 31, 2018 and December 31, 2017, respectively.


25

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


13. Supplemental Cash Flow Information
The following table provides a reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents reported with the unaudited Condensed Consolidated Balance Sheets to the total of the same amounts shown in the unaudited Condensed Consolidated Statements of Cash Flows:
 
Fair Value Hierarchy Level
 
March 31, 2018
 
December 31, 2017
 (in millions)
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Cash and cash equivalents
1
 
$
13

 
$
13

 
$
61

 
$
61

Restricted cash and restricted cash equivalents(1)
1
 
16

 
16

 
18

 
18

Non-current restricted cash and restricted cash equivalents included in Other non-current assets(1)
1
 
92

 
92

 
79

 
79

Total cash, cash equivalents, restricted cash and restricted cash equivalents shown in the unaudited Condensed Consolidated Statement of Cash Flows
 
 
$
121

 
$
121

 
$
158

 
$
158

____________________________
(1)
Current and non-current restricted cash and restricted cash equivalents primarily includes the holdback held in escrow in connection with the Bai Brands Merger. Refer to Note 2 for additional information on the Bai Brands Merger.
The following table details supplemental cash flow disclosures of non-cash investing and financing activities: 
 
For the Three Months Ended March 31,
 (in millions)
2018
 
2017
Supplemental cash flow disclosures of non-cash investing and financing activities:
 
 
 
Dividends declared but not yet paid
$
105

 
$
107

Capital expenditures included in accounts payable and other current liabilities
12

 
9

Holdback liability for acquisition of business
84

 
103

Capital lease additions
6

 
7

Supplemental cash flow disclosures:
 
 
 
Interest paid
$
15

 
$
13

Income taxes paid
3

 
7

14. Commitments and Contingencies
LEGAL MATTERS
In connection with the Maple Transaction, purported DPS stockholders have filed five lawsuits (excluding a lawsuit that has subsequently been withdrawn) against the Company and each member of the board of directors in federal court and a sixth lawsuit, against the Company, each member of the board, Maple and Merger Sub in the Delaware Court of Chancery. The complaints in each lawsuit allege certain material misrepresentations and omissions in the preliminary proxy statement filed by the Company on March 8, 2018. The complaint in the action filed in the Delaware Court of Chancery also asserts that stockholders are entitled to appraisal rights in connection with the Maple Transaction. The Company intends to vigorously contest these allegations.
In addition, the Company is occasionally subject to certain other litigation or other legal proceedings. The Company does not believe that the outcome of these, or any other, pending legal matters, individually or collectively, will have a material adverse effect on the results of operations, financial condition or liquidity of the Company.

26

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


15. Segments
As of March 31, 2018 and for the three months ended March 31, 2018, the Company's operating structure consisted of the following three operating segments:
The Beverage Concentrates segment reflects sales of the Company's branded concentrates and syrup to third-party bottlers primarily in the U.S. and Canada. Most of the brands in this segment are carbonated soft drink brands.
The Packaged Beverages segment reflects sales in the U.S. and Canada from the manufacture and distribution of finished beverages and other products, including sales of the Company's own brands and third-party brands, through both the DSD system and the WD system.
The Latin America Beverages segment reflects sales in Mexico, the Caribbean, and other international markets from the manufacture and distribution of concentrates, syrup and finished beverages.
As of December 31, 2017 and for the three months ended March 31, 2017, the Company's operating structure consisted of the four operating segments identified as a result of the Bai Brands Merger. Refer to Note 4 for additional information about the change in the Company's operating structure as of January 1, 2018.
Segment results are based on management reports. Net sales and SOP are the significant financial measures used to assess the operating performance of the Company's operating segments. Intersegment sales are recorded at cost and are eliminated in the unaudited Condensed Consolidated Statements of Income. “Unallocated corporate costs” are excluded from the Company's measurement of segment performance and include stock-based compensation expense, unrealized commodity derivative gains and losses, and certain general corporate expenses.
Information about the Company's operations by reporting segment is as follows:
 
For the Three Months Ended March 31,
(in millions)
2018
 
2017
Segment Results – Net sales
 
 
 
Beverage Concentrates
$
303

 
$
294

Packaged Beverages
1,178

 
1,118

Latin America Beverages
113

 
98

Net sales
$
1,594

 
$
1,510

 
For the Three Months Ended March 31,
 (in millions)
2018
 
2017
Segment Results – SOP
 
 
 
Beverage Concentrates
$
194

 
$
186

Packaged Beverages
150

 
141

Latin America Beverages
12

 
11

Total SOP
356

 
338

Unallocated corporate costs
96

 
80

Other operating expense (income), net
1

 
(28
)
Income from operations
259

 
286

Interest expense, net
40

 
39

Other income, net

 
(1
)
Income before provision for income taxes and equity in earnings of unconsolidated subsidiaries
$
219

 
$
248



27

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


16. Guarantor and Non-Guarantor Financial Information
The Company's outstanding senior unsecured notes (the "Notes") are fully and unconditionally guaranteed by substantially all of the Company's existing and future direct and indirect domestic subsidiaries (except one immaterial subsidiary associated with charitable purposes) (the "Guarantors"), as defined in the indentures governing the Notes. The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee, subject to the release provisions described below, the Company's obligations under the Notes. None of the Company's subsidiaries organized outside of the U.S. or immaterial subsidiaries used for charitable purposes (collectively, the "Non-Guarantors") guarantee the Notes. The subsidiary guarantees with respect to the Notes are subject to release upon the occurrence of certain events, including the sale of all or substantially all of a subsidiary's assets, the release of the subsidiary's guarantee of other indebtedness of the Company, the Company's exercise of its legal defeasance option with respect to the Notes and the discharge of the Company's obligations under the applicable indenture.
The following schedules present the financial information for Dr Pepper Snapple Group, Inc. (the "Parent"), Guarantors and Non-Guarantors. The consolidating schedules are provided in accordance with the reporting requirements of Rule 3-10 under SEC Regulation S-X for guarantor subsidiaries.

 
Condensed Consolidating Statements of Income
 
For the Three Months Ended March 31, 2018
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Net sales
$

 
$
1,473

 
$
153

 
$
(32
)
 
$
1,594

Cost of sales

 
629

 
84

 
(32
)
 
681

Gross profit

 
844

 
69

 

 
913

Selling, general and administrative expenses

 
576

 
50

 

 
626

Depreciation and amortization

 
25

 
2

 

 
27

Other operating expense (income), net

 
1

 

 

 
1

Income from operations

 
242

 
17

 

 
259

Interest expense
82

 
25

 

 
(66
)
 
41

Interest income
(23
)
 
(43
)
 
(1
)
 
66

 
(1
)
Other (income) expense, net
(2
)
 
(1
)
 
3

 

 

Income (loss) before provision (benefit) for income taxes and equity in loss of subsidiaries
(57
)
 
261

 
15

 

 
219

Provision (benefit) for income taxes
(13
)
 
63

 
4

 

 
54

Income (loss) before equity in earnings (loss) of subsidiaries
(44
)
 
198

 
11

 

 
165

Equity in earnings of consolidated subsidiaries
203

 
11

 

 
(214
)
 

Equity in loss of unconsolidated subsidiaries, net of tax

 
(6
)
 

 

 
(6
)
Net income
$
159

 
$
203

 
$
11

 
$
(214
)
 
$
159


28

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


 
Condensed Consolidating Statements of Income
 
For the Three Months Ended March 31, 2017
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Net sales
$

 
$
1,407

 
$
136

 
$
(33
)
 
$
1,510

Cost of sales

 
564

 
76

 
(33
)
 
607

Gross profit

 
843

 
60

 

 
903

Selling, general and administrative expenses
2

 
576

 
42

 

 
620

Depreciation and amortization

 
23

 
2

 

 
25

Other operating expense (income), net

 
(28
)
 

 

 
(28
)
Income from operations
(2
)
 
272

 
16

 

 
286

Interest expense
63

 
19

 

 
(42
)
 
40

Interest income
(16
)
 
(27
)
 

 
42

 
(1
)
Other (income) expense, net
(4
)
 

 
3

 

 
(1
)
Income (loss) before provision (benefit) for income taxes and equity in loss of subsidiaries
(45
)
 
280

 
13

 

 
248

Provision (benefit) for income taxes
(16
)
 
83

 
4

 

 
71

Income (loss) before equity in earnings (loss) of subsidiaries
(29
)
 
197

 
9

 

 
177

Equity in earnings of consolidated subsidiaries
206

 
9

 

 
(215
)
 

Equity in loss of unconsolidated subsidiaries, net of tax

 

 

 

 

Net income
$
177

 
$
206

 
$
9

 
$
(215
)
 
$
177

 
Condensed Consolidating Statements of Comprehensive Income
 
For the Three Months Ended March 31, 2018
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Comprehensive income (loss)
$
178

 
$
220

 
$
27

 
$
(247
)
 
$
178

 
Condensed Consolidating Statements of Comprehensive Income
 
For the Three Months Ended March 31, 2017
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Comprehensive income (loss)
$
200

 
$
227

 
$
30

 
$
(257
)
 
$
200


29

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


 
Condensed Consolidating Balance Sheets
 
As of March 31, 2018
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$
13

 
$

 
$
13

Restricted cash and cash equivalents

 
15

 
1

 

 
16

Accounts receivable:
 
 
 
 
 
 
 
 
 
Trade, net

 
620

 
80

 

 
700

Other
6

 
33

 
10

 

 
49

Related party receivable
25

 
48

 

 
(73
)
 

Inventories

 
211

 
32

 

 
243

Prepaid expenses and other current assets
482

 
211

 
19

 
(487
)
 
225

Total current assets
513

 
1,138

 
155

 
(560
)
 
1,246

Property, plant and equipment, net

 
1,051

 
147

 

 
1,198

Investments in consolidated subsidiaries
9,555

 
324

 

 
(9,879
)
 

Investments in unconsolidated subsidiaries

 
36

 

 

 
36

Goodwill

 
3,540

 
24

 

 
3,564

Other intangible assets, net

 
3,733

 
51

 

 
3,784

Long-term receivable, related parties
3,298

 
6,335

 

 
(9,633
)
 

Other non-current assets
64

 
195

 
29

 
(2
)
 
286

Deferred tax assets
10

 

 
65

 
(10
)
 
65

Total assets
$
13,440

 
$
16,352

 
$
471

 
$
(20,084
)
 
$
10,179

 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$

 
$
344

 
$
33

 
$

 
$
377

Related party payable
43

 
23

 
7

 
(73
)
 

Deferred revenue

 
67

 
2

 
(5
)
 
64

Short-term borrowings and current portion of long-term obligations
369

 
14

 

 

 
383

Income taxes payable

 
521

 

 
(482
)
 
39

Other current liabilities
164

 
528

 
69

 

 
761

Total current liabilities
576

 
1,497

 
111

 
(560
)
 
1,624

Long-term obligations to third parties
3,963

 
172

 

 

 
4,135

Long-term obligations to related parties
6,335

 
3,298

 

 
(9,633
)
 

Deferred tax liabilities

 
633

 

 
(10
)
 
623

Non-current deferred revenue

 
1,015

 
25

 
(2
)
 
1,038

Other non-current liabilities
80

 
182

 
11

 

 
273

Total liabilities
10,954

 
6,797

 
147

 
(10,205
)
 
7,693

Total stockholders' equity
2,486

 
9,555

 
324

 
(9,879
)
 
2,486

Total liabilities and stockholders' equity
$
13,440

 
$
16,352

 
$
471

 
$
(20,084
)
 
$
10,179



30

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


 
Condensed Consolidating Balance Sheets
 
As of December 31, 2017
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$
15

 
$
46

 
$

 
$
61

Restricted cash and cash equivalents

 
18

 

 

 
18

Accounts receivable:
 
 
 
 
 
 
 
 
 
Trade, net

 
595

 
73

 

 
668

Other
1

 
35

 
6

 

 
42

Related party receivable
20

 
42

 

 
(62
)
 

Inventories

 
199

 
30

 

 
229

Prepaid and other current assets
473

 
83

 
18

 
(475
)
 
99

Total current assets
494

 
987

 
173

 
(537
)
 
1,117

Property, plant and equipment, net

 
1,062

 
136

 

 
1,198

Investments in consolidated subsidiaries
9,373

 
332

 

 
(9,705
)
 

Investments in unconsolidated subsidiaries

 
24

 

 

 
24

Goodwill

 
3,539

 
22

 

 
3,561

Other intangible assets, net

 
3,733

 
48

 

 
3,781

Long-term receivable, related parties
3,278

 
6,233

 

 
(9,511
)
 

Other non-current assets
65

 
195

 
22

 
(3
)
 
279

Deferred tax assets
11

 

 
62

 
(11
)
 
62

Total assets
$
13,221

 
$
16,105

 
$
463

 
$
(19,767
)
 
$
10,022

 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$

 
$
333

 
$
32

 
$

 
$
365

Related party payable
37

 
20

 
5

 
(62
)
 

Deferred revenue

 
68

 
2

 
(6
)
 
64

Short-term borrowings and current portion of long-term obligations
66

 
13

 

 

 
79

Income taxes payable

 
479

 
1

 
(469
)
 
11

Other current liabilities
133

 
532

 
54

 

 
719

Total current liabilities
236

 
1,445

 
94

 
(537
)
 
1,238

Long-term obligations to third parties
4,230

 
170

 

 

 
4,400

Long-term obligations to related parties
6,233

 
3,278

 

 
(9,511
)
 

Deferred tax liabilities

 
625

 

 
(11
)
 
614

Non-current deferred revenue

 
1,032

 
26

 
(3
)
 
1,055

Other non-current liabilities
71

 
182

 
11

 

 
264

Total liabilities
10,770

 
6,732

 
131

 
(10,062
)
 
7,571

Total stockholders' equity
2,451

 
9,373

 
332

 
(9,705
)
 
2,451

Total liabilities and stockholders' equity
$
13,221

 
$
16,105

 
$
463

 
$
(19,767
)
 
$
10,022



31

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


 
Condensed Consolidating Statements of Cash Flows
 
For the Three Months Ended March 31, 2018
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(29
)
 
$
150

 
$
19

 
$
(37
)
 
$
103

Investing activities:
 
 
 
 
 
 
 
 
 
Acquisition of business

 
(2
)
 

 

 
(2
)
Purchase of property, plant and equipment

 
(35
)
 
(6
)
 

 
(41
)
Purchase of intangible assets

 
(3
)
 

 

 
(3
)
Investment in unconsolidated subsidiaries

 
(19
)
 

 

 
(19
)
Proceeds from disposals of property, plant and equipment

 
1

 

 

 
1

Issuance of related party notes receivable

 
(102
)
 

 
102

 

Other, net
(4
)
 

 

 

 
(4
)
Net cash (used in) provided by investing activities
(4
)
 
(160
)
 
(6
)
 
102

 
(68
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of related party debt
102

 

 

 
(102
)
 

Net issuance of commercial paper
54

 

 

 

 
54

Dividends paid
(104
)
 

 
(37
)
 
37

 
(104
)
Tax withholdings related to net share settlements of certain stock awards
(21
)
 

 

 

 
(21
)
Proceeds from stock options exercised
2

 

 

 

 
2

Capital lease payments

 
(4
)
 

 

 
(4
)
Net cash (used in) provided by financing activities
33

 
(4
)
 
(37
)
 
(65
)
 
(73
)
Cash and cash equivalents — net change from:
 

 
 

 
 

 
 

 
 

Operating, investing and financing activities

 
(14
)
 
(24
)
 

 
(38
)
Effect of exchange rate changes on cash and cash equivalents

 

 
1

 

 
1

Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period

 
111

 
47

 

 
158

Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
$

 
$
97

 
$
24

 
$

 
$
121


32

Table of Contents
DR PEPPER SNAPPLE GROUP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited, Continued)


 
Condensed Consolidating Statements of Cash Flows
 
For the Three Months Ended March 31, 2017
 (in millions)
Parent
 
Guarantors
 
Non-Guarantors
 
Eliminations
 
Total
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(23
)
 
$
122

 
$
8

 
$
(10
)
 
$
97

Investing activities:
 
 
 
 
 
 
 
 
 
Acquisition of business

 
(1,548
)
 

 

 
(1,548
)
Cash acquired in step acquisition of unconsolidated subsidiaries

 
3

 

 

 
3

Purchase of property, plant and equipment

 
(15
)
 
(1
)
 

 
(16
)
Purchase of intangible assets

 
(1
)
 

 

 
(1
)
Investments in unconsolidated subsidiaries

 
(1
)
 

 

 
(1
)
Proceeds from disposals of property, plant and equipment

 
1

 

 

 
1

Issuance of related party notes receivable

 
(169
)
 

 
169

 

Other, net
(7
)
 

 

 

 
(7
)
Net cash (used in) provided by investing activities
(7
)
 
(1,730
)
 
(1
)
 
169

 
(1,569
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of related party debt
169

 

 

 
(169
)
 

Repurchase of shares of common stock
(28
)
 

 

 

 
(28
)
Dividends paid
(97
)
 

 
(10
)
 
10

 
(97
)
Tax withholdings related to net share settlements of certain stock awards
(30
)
 

 

 

 
(30
)
Proceeds from stock options exercised
17

 

 

 

 
17

Deferred financing charges paid
(1
)
 

 

 

 
(1
)
Capital lease payments

 
(3
)
 

 

 
(3
)
Net cash (used in) provided by financing activities
30

 
(3
)
 
(10
)
 
(159
)
 
(142
)
Cash and cash equivalents — net change from:
 
 
 
 
 
 
 
 
 
Operating, investing and financing activities

 
(1,611
)
 
(3
)
 

 
(1,614
)
Effect of exchange rate changes on cash and cash equivalents

 
1

 
2

 

 
3

Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period

 
1,736

 
51

 

 
1,787

Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
$

 
$
126

 
$
50

 
$

 
$
176


33

Table of Contents


ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 
You should read the following discussion in conjunction with our audited consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2017 (the "Annual Report").
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation, labor matters and availability of raw materials. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "may," "will," "expect," "anticipate," "believe," "estimate," "plan," "intend" or the negative of these terms or similar expressions in this Quarterly Report on Form 10-Q. We have based these forward-looking statements on our current views with respect to future events and financial performance. Our actual financial performance could differ materially from those projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and our financial performance may be better or worse than anticipated. Given these uncertainties, you should not put undue reliance on any forward-looking statements. All of the forward-looking statements are qualified in their entirety by reference to the factors discussed under "Risk Factors" in Part I, Item 1A of our Annual Report. Forward-looking statements represent our estimates and assumptions only as of the date that they were made. We do not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, after the date of this Quarterly Report on Form 10-Q, except to the extent required by applicable securities laws.
This Quarterly Report on Form 10-Q contains the names of some of our owned or licensed trademarks, trade names and service marks, which we refer to as our brands. All of the product names included in this Quarterly Report on Form 10-Q are either our registered trademarks or those of our licensors.
PROPOSED MAPLE MERGER
On January 29, 2018, DPS entered into the Merger Agreement by and among DPS, Maple and Merger Sub, whereby Merger Sub will be merged with and into Maple, with Maple surviving the merger as a wholly-owned subsidiary of the Company. For financial reporting and accounting purposes, Maple will be the acquirer of DPS upon completion of the Maple Merger.
Maple is the indirect parent of Keurig, through which Maple conducts all of its operations. Keurig is a leading producer of specialty coffee and innovative single serve brewing systems. The combined businesses will create Keurig Dr Pepper Inc., a new beverage company of scale with a portfolio of iconic consumer brands and expanded distribution capability to reach virtually every point-of-sale in North America.
In consideration for the Maple Merger, each share of common stock of Maple issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive the Acquisition Shares. Additionally, the Merger Agreement provides that DPS will declare a special cash dividend equal to $103.75 per share, subject to any withholding of taxes required by law, payable to holders of its common stock as of the business day immediately prior to the completion of the Maple Merger. As a result, upon completion of the Maple Transaction, the former equityholders of Maple will own approximately 87% of our common stock and our continuing stockholders will own approximately 13% on a fully diluted basis.
The completion of the Maple Transaction requires the approval of the holders of DPS common stock of (i) an amendment to the DPS certificate of incorporation to increase the number of authorized shares of common stock and to change DPS' name to "Keurig Dr Pepper Inc." and (ii) the issuance of the Acquisition Shares pursuant to the Merger Agreement. On March 8, 2018, DPS filed a preliminary proxy statement with the SEC with respect to an annual meeting of stockholders at which the Stockholder Approvals will be sought.
See Note 2 of the Notes to our Unaudited Condensed Consolidated Financial Statements for further information related to the Maple Transaction.
OVERVIEW
We are a leading integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the U.S., Canada and Mexico with a diverse portfolio of flavored (non-cola) CSDs and NCBs, including ready-to-drink teas, juices, juice drinks, water and mixers. Our brand portfolio includes popular CSD brands such as Dr Pepper, Canada Dry, Peñafiel, Squirt, 7UP, Crush, A&W, Sunkist soda and Schweppes, and NCB brands such as Snapple, Hawaiian Punch, Mott's, Clamato, Bai, Mr & Mrs T mixers and Rose's. Our largest brand, Dr Pepper, is a leading flavored CSD in the U.S. as reported by Information Resources, Inc. We have some of the most recognized beverage brands in North America, with significant consumer awareness levels and long histories that evoke strong emotional connections with consumers. 

34

Table of Contents


We operate as an integrated brand owner, manufacturer and distributor through our three reporting segments. We believe our integrated business model strengthens our route-to-market and provides opportunities for net sales and profit growth through the alignment of the economic interests of our brand ownership and our manufacturing and distribution businesses through both our DSD system and our WD delivery system. Our integrated business model enables us to be more flexible and responsive to the changing needs of our large retail customers and allows us to more fully leverage our scale and reduce costs by creating greater geographic manufacturing and distribution coverage.
The beverage market is subject to some seasonal variations. Our beverage sales are generally higher during the warmer months and also can be influenced by the timing of holidays and religious festivals as well as weather fluctuations.
BEVERAGE CONCENTRATES
Our Beverage Concentrates segment is principally a brand ownership business. In this segment we manufacture and sell beverage concentrates in the U.S. and Canada. Most of the brands in this segment are CSD brands. Key brands include Dr Pepper, Canada Dry, Squirt, 7UP, Crush, A&W, Schweppes, Sunkist soda, RC Cola, Sundrop, Vernors, Diet Rite and the concentrate form of Hawaiian Punch.
Almost all of our beverage concentrates are manufactured at our plant in St. Louis, Missouri.
Beverage concentrates are shipped to third-party bottlers, as well as to our own manufacturing systems, who combine them with carbonation, water, sweeteners and other ingredients, package the combined product in PET containers, glass bottles and aluminum cans, and sell them as finished beverages to retailers. Beverage concentrates are also manufactured into syrup, which is shipped to fountain customers, such as fast food restaurants, who mix the syrup with water and carbonation to create a finished beverage at the point of sale to consumers. Dr Pepper represents most of our fountain channel volume. Concentrate prices historically have been reviewed and adjusted at least on an annual basis.
Our Beverage Concentrates brands are sold by our bottlers, including our own Packaged Beverages segment, through all major retail channels including supermarkets, fountains, mass merchandisers, club stores, vending machines, convenience stores, gas stations, small groceries, drug chains and dollar stores.
PACKAGED BEVERAGES
Our Packaged Beverages reporting segment is principally a brand ownership, manufacturing and distribution business. In this segment, we primarily manufacture and distribute packaged beverages and other products, including our brands, third-party owned brands and certain private label beverages, primarily in the U.S. and Canada. Key NCB brands in this segment include Snapple, Hawaiian Punch, Mott's, FIJI mineral water, Clamato, Bai, Yoo-Hoo, Deja Blue, ReaLemon, BODYARMOR, Vita Coco coconut water, AriZona tea, Mr and Mrs T mixers, Nantucket Nectars, Garden Cocktail, Mistic and Rose's. Key CSD brands in this segment include Dr Pepper, 7UP, Canada Dry, A&W, Sunkist soda, Squirt, RC Cola, Big Red, Vernors, Venom, IBC, Diet Rite and Sun Drop. 
Additionally, we distribute third-party brands such as FIJI mineral water, Big Red, BODYARMOR, Vita Coco coconut water, AriZona tea, CORE Hydration, Neuro drinks, Sunny Delight, High Brew, Hydrive energy drinks and Sparkling Fruit2O. Although the majority of our Packaged Beverages' net sales relate to our brands, we also provide a route-to-market for these third party brand owners seeking effective distribution for their new and emerging brands. These brands give us exposure in certain markets to fast growing segments of the beverage industry with minimal capital investment. 
Our Packaged Beverages' products are manufactured in multiple facilities across the U.S. and are sold or distributed to retailers and their warehouses by our own distribution network or by third-party distributors. The raw materials used to manufacture our products include aluminum cans and ends, PET bottles and caps, glass bottles and closures, paper products, sweeteners, juices, water and other ingredients.
We sell our Packaged Beverages' products through our DSD system and our WD system, both of which include the sales to all major retail channels, including supermarkets, fountains, mass merchandisers, club stores, vending machines, convenience stores, gas stations, small groceries, drug chains and dollar stores.
LATIN AMERICA BEVERAGES
Our Latin America Beverages segment is a brand ownership, manufacturing and distribution business. This segment participates mainly in the carbonated mineral water, flavored CSD, bottled water and vegetable juice categories, with particular strength in carbonated mineral water, vegetable juice categories and grapefruit flavored CSDs. Key brands include Peñafiel, Squirt, Aguafiel, Clamato and Crush.
In Mexico, we manufacture and distribute our products through our bottling operations and third party bottlers and distributors. We sell our finished beverages through all major Mexican retail channels, including "mom and pop" stores, supermarkets, hypermarkets, convenience stores and on-premise channels. In the Caribbean, we distribute our products through third-party bottlers and distributors. We have also begun to distribute certain products in other international jurisdictions through various third-party bottlers and distributors.

35

Table of Contents


VOLUME
In evaluating our performance, we consider different volume measures depending on whether we sell beverage concentrates or finished beverages.
Beverage Concentrates Sales Volume
In our Beverage Concentrates segment, we measure our sales volume in two ways: (1) "concentrate case sales" and (2) "bottler case sales." The unit of measurement for both concentrate case sales and bottler case sales equals 288 fluid ounces of finished beverage, the equivalent of 24 twelve ounce servings.
Concentrate case sales represent units of measurement for concentrates sold by us to our bottlers and distributors. A concentrate case is the amount of concentrate needed to make one case of 288 fluid ounces of finished beverage. It does not include any other component of the finished beverage other than concentrate. Our net sales in our concentrate businesses are based on our sales of concentrate cases.
Although net sales in our concentrate businesses are based on concentrate case sales, we believe that bottler case sales are also a significant measure of our performance because they measure sales of packaged beverages into retail channels.
Packaged Beverages and Latin America Beverages Sales Volume
In our Packaged Beverages and Latin America Beverages segments, we measure volume as case sales to customers. A case sale represents a unit of measurement equal to 288 fluid ounces of packaged beverage sold by us. Case sales include both our owned brands and certain brands licensed to and/or distributed by us.
Volume in Bottler Case Sales
In addition to sales volume, we measure volume in bottler case sales ("volume (BCS)") as sales of packaged beverages, in equivalent 288 fluid ounce cases, sold by us and our bottling partners to retailers and independent distributors. Our contract manufacturing sales are not included or reported as part of volume (BCS).
Bottler case sales and concentrates and packaged beverage sales volumes are not equal during any given period due to changes in bottler concentrates inventory levels, which can be affected by seasonality, bottler inventory and manufacturing practices and the timing of price increases and new product introductions.

36

Table of Contents


EXECUTIVE SUMMARY - FINANCIAL OVERVIEW AND RECENT DEVELOPMENTS
chart-60f60653e86f57d7990.jpg    chart-714f0763e7135777b97.jpg
chart-4d6ac9bef336510ca2b.jpg    chart-03a5e0beaba354b2bba.jpg
Net sales grew approximately 6%, due primarily to 2.5% growth in sales volumes, as the shift of the Easter holiday from the second quarter in 2017 to the first quarter of 2018 and the initial buy-in for the Canada Dry Lemonade product innovation each added approximately 1% of growth for the three months ended March 31, 2018. Favorable product and package mix, segment mix and foreign currency translation also contributed to the growth, which was partially offset by incremental promotional activity.
Income from operations declined 9% driven primarily by the unfavorable comparison to the gain on the step-acquisition of Bai Brands in the prior year. The increase in net sales was almost fully offset by increases in cost of sales and SG&A expenses, primarily driven by higher commodity costs, including the unfavorable mark-to-market comparison on our derivative instruments, $14 million of logistic costs and higher people costs, driven by inflationary increases, frontline investment and the growth in sales volumes.
Net income decreased $18 million driven primarily by the unfavorable comparison to the gain on the step-acquisition of Bai Brands in the prior year, which impacted diluted earnings per share by $0.10 for the three months ended March 31, 2017.
On January 5, 2018, the Company acquired a 5.1% equity interest in Core for $18 million.
During the first quarter of 2018, our Board declared a dividend of $0.58 per share, which was paid on April 12, 2018, to shareholders of record as of March 21, 2018.

37

Table of Contents


RESULTS OF OPERATIONS
We eliminate from our financial results all intercompany transactions between entities included in our consolidated financial statements and the intercompany transactions with our equity method investees.
References in the financial tables to percentage changes that are not meaningful are denoted by "NM."
Three Months Ended March 31, 2018 Compared to Three Months Ended March 31, 2017
Consolidated Operations
The following table sets forth our unaudited consolidated results of operations for the three months ended March 31, 2018 and 2017:
 
For the Three Months Ended March 31,
 
 
 
 
 
2018
 
2017
 
Dollar
 
Percentage
($ in millions)
Dollars
 
Percent
 
Dollars
 
Percent
 
Change
 
Change
Net sales
$
1,594

 
100.0
 %
 
$
1,510

 
100.0
 %
 
$
84

 
6
 %
Cost of sales
681

 
42.7

 
607

 
40.2

 
74

 
12

Gross profit
913

 
57.3

 
903

 
59.8

 
10

 
1

SG&A expenses
626

 
39.3

 
620

 
41.1

 
6

 
1

Other operating expense (income), net
1

 
0.1

 
(28
)
 
(1.9
)
 
29

 
NM

Income from operations
259

 
16.2

 
286

 
18.9

 
(27
)
 
(9
)
Provision for income taxes
54

 
3.4

 
71

 
4.7

 
(17
)
 
(24
)
Equity in loss of unconsolidated subsidiaries, net of tax
(6
)
 
(0.4
)
 

 

 
(6
)
 
NM

Effective tax rate
24.7
%
 
NM

 
28.6
%
 
NM

 
NM

 
NM

Volume (BCS). Volume (BCS) increased 2% for the three months ended March 31, 2018 compared with the three months ended March 31, 2017, which included the shift of the Easter holiday activity into the first quarter of 2018. In the U.S. and Canada, volume grew 3%, and in Mexico and the Caribbean, volume was flat, compared with the year ago period. Branded CSD and NCB volumes grew 2% and 6%, respectively, in the current period.
In branded CSDs, Canada Dry increased 11% due to product innovation and continued growth in the ginger ale category. Dr Pepper grew 1% compared to the year ago period as increases in our fountain business were partially offset by declines in TEN and diet. Squirt increased 3% while Peñafiel grew 2% as a result of distribution gains and product innovation in our Latin America Beverages segment. Schweppes also increased by 2% due to continued growth in the ginger ale category. These increases were partially offset by a 2% decline in 7UP. Our other CSD brands were 2% lower, led by Rockstar as a result of the loss of distribution rights in the prior year. A&W was flat compared to the year ago period.
In branded NCBs, our growth allied brands gained 32% due primarily to distribution gains for BODYARMOR and Core, and product innovation and promotional activity for BODYARMOR. Bai increased 54% driven by distribution gains, product innovation and promotional activity. Bai also included three months of shipments to third-party distributors for the three months ended March 31, 2018 compared with two months of similar shipments in the prior year period due to the timing of the Bai Brands Merger. Mott's grew 6% compared to the prior period due to growth in juice, driven by product innovation, and sauce products. Snapple and Clamato both increased 1% compared with the year ago period. These increases were partially offset by our other NCB brands, which were 2% lower compared to the prior period, led by Aguafiel and AriZona.

38

Table of Contents


Net Sales. Net sales increased $84 million, or approximately 6%, for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. The primary drivers of the increase in net sales included:
The increase in branded shipments, which excluded the loss of the Rockstar distribution rights in the prior year, grew net sales by 2.5% and included the shift of the Easter holiday activity into the first quarter of 2018;
Favorable product and package mix, which raised net sales by 2.0%;
Favorable segment mix, which increased our net sales by 1.0%;
Favorable foreign currency translation of $9 million, which grew our net sales by 1.0%;
The increase in contract manufacturing activity, which raised our net sales by 0.5%;
The loss of the Rockstar distribution rights in the prior year, which lowered net sales by 0.5%; and
Increased promotional activity, which decreased net sales by 0.5%.
Gross Profit. Gross profit increased $10 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. Gross margin was 57.3% for the three months ended March 31, 2018 compared to the gross margin of 59.8% for the three months ended March 31, 2017. The primary drivers of the change in gross margin included:
Unfavorable comparison of $30 million in our mark-to-market activity on commodity derivative contracts, which lowered our gross margin by 2.0%;
Higher commodity costs, led by packaging, combined with the unfavorable change in our last-in, first-out ("LIFO") inventory provision, reduced our gross margin by 1.4%;
Increase in our other manufacturing costs, which decreased our gross margin by 0.4%.
Favorable product and package mix, which raised our gross margin by 0.7%; and
Increase in our gross margin of 0.6% related to the favorable comparison to the $9 million initial profit in stock adjustment as a result of the Bai Brands Merger recorded during the first quarter of 2017.
The unfavorable mark-to-market activity on commodity derivative contracts within cost of sales, which is included in unallocated corporate costs, for the three months ended March 31, 2018 was $12 million in unrealized losses versus $18 million in unrealized gains in the year ago period.
SG&A Expenses. SG&A expenses increased $6 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. The primary drivers of the increase included $14 million of logistic costs, $12 million of transaction and integration expenses for the pending Maple Transaction, higher people costs, driven by inflationary increases, frontline investment and the growth in sales volumes, and an increase in incentive compensation. These drivers were partially offset by the favorable comparison to $18 million of transaction and integration expenses for the Bai Brands Merger in the prior year, a $15 million favorable comparison in the mark-to-market activity on commodity derivative contracts, and a $4 million planned decrease in marketing investments.
The favorable mark-to-market activity on commodity derivative contracts within SG&A expenses, which is included in unallocated corporate costs, for the three months ended March 31, 2018 was $1 million in unrealized gains versus $14 million in unrealized losses in the year ago period.
Income from Operations. Income from operations decreased $27 million to $259 million for the three months ended March 31, 2018 due primarily to unfavorable comparison to the $28 million gain on the step-acquisition of Bai Brands recorded in the prior year and the increase in SG&A expenses, partially offset by the increase in gross profit.
Effective Tax Rate. The effective tax rates for the three months ended March 31, 2018 and 2017 were 24.7% and 28.6%, respectively. For the three months ended March 31, 2018, the provision for income taxes was lower than the prior year quarter primarily due to the TCJA which was enacted in December 2017. See Note 5 of the Notes to our Unaudited Condensed Consolidated Financial Statements for additional information.
Equity in loss of unconsolidated subsidiaries, net of tax. This line represents our proportionate share of net income or loss from each of our equity method investees. For the three months ended March 31, 2018, a charge of $6 million reflects the unfavorable results of our 15.5% interest in BA Sports Nutrition, LLC.

39

Table of Contents


Results of Operations by Segment
The following tables set forth net sales and SOP for our segments for the three months ended March 31, 2018 and 2017, as well as the other amounts necessary to reconcile our total segment results to our consolidated results presented in accordance with U.S. GAAP:
 
For the Three Months Ended
 
March 31,
(in millions)
2018
 
2017
Segment Results — Net sales
 
 
 
Beverage Concentrates
$
303

 
$
294

Packaged Beverages
1,178

 
1,118

Latin America Beverages
113

 
98

Net sales
$
1,594

 
$
1,510

 
 
 
 
 
For the Three Months Ended
 
March 31,
(in millions)
2018
 
2017
Segment Results — SOP
 
 
 
Beverage Concentrates
$
194

 
$
186

Packaged Beverages
150

 
141

Latin America Beverages
12

 
11

Total SOP
356

 
338

Unallocated corporate costs
96

 
80

Other operating expense (income), net
1

 
(28
)
Income from operations
259

 
286

Interest expense, net
40

 
39

Other income, net

 
(1
)
Income before provision for income taxes and equity in loss of unconsolidated subsidiaries
$
219

 
$
248

BEVERAGE CONCENTRATES
The following table details our Beverage Concentrates segment's net sales and SOP for the three months ended March 31, 2018 and 2017:
 
For the Three Months Ended March 31,
 
Dollar
 
Percent
(in millions)
2018
 
2017
 
Change
 
Change
Net sales
$
303

 
$
294

 
$
9

 
3
%
SOP
194

 
186

 
8

 
4

Net Sales. Net sales increased $9 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. The increase was due to higher pricing, favorable product mix and a 1% increase in concentrate case sales.
SOP. SOP increased $8 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017, primarily driven by an increase in net sales which was partially offset by higher cost of sales. The increase in cost of sales was primarily the result of higher costs associated with product mix, an increase in commodity costs, led by flavors, and higher other manufacturing costs.
Volume (BCS). Volume (BCS) increased 2% for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. Canada Dry had an 8% gain due to continued growth in the ginger ale category and product innovation. Dr Pepper grew 1% as increases in our fountain business were partially offset by declines in TEN and diet. Schweppes also increased 1% as a result of continued growth in the ginger ale category. These increases were partially offset by a 3% decrease in 7UP and a 1% decline in A&W compared to the year ago period. Our other brands were flat compared to the prior year period.

40

Table of Contents


PACKAGED BEVERAGES
The following table details our Packaged Beverages segment's net sales and SOP for the three months ended March 31, 2018 and 2017:
 
For the Three Months Ended March 31,
 
Dollar
 
Percent
(in millions)
2018
 
2017
 
Change
 
Change
Net sales
$
1,178

 
$
1,118

 
$
60

 
5
%
SOP
150

 
141

 
9

 
6

Volume. Branded CSD volumes increased 2% for the three months ended March 31, 2018 compared with the three months ended March 31, 2017, which included the shift of the Easter holiday activity into the first quarter of 2018. Canada Dry increased 16% due to product innovation and continued growth in the ginger ale category, while Dr Pepper increased 1% as growth in regular and diet was partially offset by declines in TEN. A&W increased 1%. Our other CSD brands grew 1% despite the loss of the Rockstar distribution rights in the prior year. These increases were partially offset by a 3% decrease in 7UP.
Branded NCB volumes increased 7% for the three months ended March 31, 2018 compared with the three months ended March 31, 2017, which also included the shift of the Easter holiday activity into the first quarter of 2018. Our growth allied brands gained 32% due primarily to distribution gains for BODYARMOR and Core, and product innovation and promotional activity for BODYARMOR. Bai increased 54% driven by distribution gains, product innovation and promotional activity. Bai also included three months of shipments to third-party distributors for the three months ended March 31, 2018 compared with two months of similar shipments in the prior year period due to the timing of the Bai Brands Merger. Mott's increased 5% compared to the prior period due to growth in juice, driven by product innovation, and sauce products. Snapple grew 3%, while Clamato increased 5%. These increases were partially offset by a 2% decline in our other NCB brands, led by AriZona.
Contract manufacturing volume increased 12% for the three months ended March 31, 2018 compared with the three months ended March 31, 2017.
Net Sales. Net sales increased $60 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. Net sales increased due to higher sales volumes, favorable product and package mix and an increase in contract manufacturing. These increases were partially offset by increased promotional activity and the loss of the Rockstar distribution rights in the prior year.
SOP. SOP increased $9 million for the three months ended March 31, 2018, compared with the three months ended March 31, 2017 as the increase in net sales was partially offset by increases in cost of sales and SG&A expenses.
Cost of sales increased as a result of higher costs associated with increased sales volumes and higher commodity costs, led by packaging. SG&A expenses were higher as a result of $13 million in logistic costs and higher people costs, driven by inflationary increases, frontline investment and the growth in sales volumes. These drivers were partially offset by a $4 million planned decline in marketing investments.
LATIN AMERICA BEVERAGES
The following table details our Latin America Beverages segment's net sales and SOP for the three months ended March 31, 2018 and 2017:
 
For the Three Months Ended March 31,
 
Dollar
 
Percent
(in millions)
2018
 
2017
 
Change
 
Change
Net sales
$
113

 
$
98

 
$
15

 
15
%
SOP
12

 
11

 
1

 
9

Volume. Sales volume was flat for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. Peñafiel increased by 2% as a result of distribution gains and product innovation, which was fully offset by a 2% decrease in Clamato, primarily due to lower sales to a third party bottler, and a 4% decline in our other brands. Squirt was unchanged in the current period.
Net Sales. Net sales increased $15 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017. Net sales increased as a result of favorable foreign currency translation of $7 million, higher pricing and favorable product and package mix.
SOP. SOP increased $1 million for the three months ended March 31, 2018 compared with the three months ended March 31, 2017, driven by increases in net sales, partially offset by increases in cost of sales and SG&A expenses.

41

Table of Contents


Cost of sales increased compared to the prior period as a result of higher commodity costs, led by packaging, an increase in costs associated with product and package mix, and unfavorable foreign currency effects. SG&A expenses increased compared to the prior year period as a result of unfavorable foreign currency effects, an increase in planned marketing investments and an increase in people costs. The impact of the unfavorable foreign currency effects on cost of sales and SG&A expenses totaled $4 million.
Non-GAAP Financial Information
We report our financial results in accordance with U.S. GAAP. However, we believe that certain non-GAAP measures that reflect the way management evaluates the business may provide investors with additional information regarding our results, trends and ongoing performance on a comparable basis.
Core results is defined as reported results adjusted for the unrealized mark-to-market impact of commodity derivatives and interest rate derivatives not designated as hedges in accordance with U.S. GAAP and certain items that are excluded for comparison to prior year periods. Management believes that core results provide a comparable basis to evaluate our results period over period, which is also used as the basis for incentive compensation for our employees. As a result, the method used to calculate our non-GAAP financial measures may differ from the methods used by other companies to calculate their non-GAAP measures.
The certain item excluded for the three months ended March 31, 2018, is the impact of transaction and integration expenses associated with the Maple Merger and the Bai Brands Merger. The certain item excluded for the the three months ended March 31, 2017, is the impact of transaction and integration expenses associated with the Bai Brands Merger
 
For the Three Months Ended March 31, 2018
 
Reported
 
Mark to Market
 
Transition and Integration Expenses
 
Core
Income from operations
$
259

 
$
11

 
$
13

 
$
283

 
For the Three Months Ended March 31, 2017
 
Reported
 
Mark to Market
 
Transition and Integration Expenses
 
Core
Income from operations
$
286

 
$
(4
)
 
$
19

 
$
301

CRITICAL ACCOUNTING ESTIMATES
The process of preparing our consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses. Critical accounting estimates are both fundamental to the portrayal of a company’s financial condition and results and require difficult, subjective or complex estimates and assessments. These estimates and judgments are based on historical experience, future expectations and other factors and assumptions we believe to be reasonable under the circumstances. The most significant estimates and judgments are reviewed on an ongoing basis and revised when necessary. These critical accounting estimates are discussed in greater detail in our Annual Report on Form 10-K for the year ended December 31, 2017.
LIQUIDITY AND CAPITAL RESOURCES
Trends and Uncertainties Affecting Liquidity
Customer and consumer demand for our products may be impacted by the risk factors discussed under "Risk Factors" in Part I, Item 1A, of our Annual Report on Form 10-K that could have a material effect on production, delivery and consumption of our products in the U.S., Mexico and the Caribbean or Canada, which could result in a reduction in our sales volume. Similarly, disruptions in financial and credit markets may impact our ability to manage normal commercial relationships with our customers, suppliers and creditors. These disruptions could have a negative impact on the ability of our customers to timely pay their obligations to us, thus reducing our cash flow, or the ability of our vendors to timely supply materials.

42

Table of Contents


We believe that the following events, trends and uncertainties may also impact liquidity:
upon consummation of the Maple Transaction, we will incur substantial third party indebtedness;
our ability to issue unsecured commercial paper notes ("Commercial Paper") on a private placement basis up to a maximum aggregate amount outstanding at any time of $500 million, which, pending completion of the Maple Transaction has been limited to $200 million pursuant to the Merger Agreement unless we obtain Maple's approval;
continued payment of dividends;
continued capital expenditures;
fluctuations in our tax obligations;
seasonality of our operating cash flows could impact short-term liquidity;
our continued integration of Bai Brands;
future equity investments in allied brands; and
future mergers or acquisitions of regional bottling companies, distributors and/or distribution rights to further extend our geographic coverage.
Additionally, DPS expects that all series of senior unsecured notes outstanding under the indentures dated April 30, 2008 and December 15, 2009 or any related supplement (the “Indentures”) will remain outstanding upon consummation of the Maple Transaction. The Indentures require us (or any successor to DPS) to offer to repurchase all outstanding notes of a series at 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of repurchase if DPS undergoes a change of control and the credit rating of the relevant series is downgraded to below investment grade by each of Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Ratings Services (“S&P”) within 60 days after the change of control. Because the Maple Transaction will constitute a change of control of DPS, if the credit ratings of any series of notes issued pursuant to the Indentures are downgraded to below investment grade within 60 days following the effectiveness of the merger, the combined company will be required to offer to repurchase all outstanding notes of each such series on such terms. However, based on statements from S&P and Moody’s on January 29, 2018 and January 30, 2018, respectively, regarding details of the consideration to be paid in connection with the Maple Transaction, the proposed capital structure of the combined company, including the proposed refinancing of certain indebtedness of Maple outstanding prior to the consummation of the Maple Transaction, the anticipated value creation and synergies of the Maple Transaction and the anticipated timing of closing of the Maple Transaction, DPS anticipates that these notes will continue to be rated investment grade following the closing date and that the combined company will not be required to make a change of control offer.
Financing Arrangements
Refer to Note 6 of the Notes to our Unaudited Condensed Consolidated Financial Statements for management's discussion of financing arrangements.
Liquidity
Based on our current and anticipated level of operations, we believe that our operating cash flows will be sufficient to meet our anticipated obligations for the next twelve months. To the extent that our operating cash flows are not sufficient to meet our liquidity needs, we may utilize cash on hand or amounts available under our financing arrangements, if necessary.
The following table summarizes our cash activity for the three months ended March 31, 2018 and 2017:
 
For the Three Months Ended March 31,
(in millions)
2018
 
2017
Net cash provided by operating activities
$
103

 
$
97

Net cash used in investing activities
(68
)
 
(1,569
)
Net cash used in financing activities
(73
)
 
(142
)
NET CASH PROVIDED BY OPERATING ACTIVITIES
Net cash provided by operating activities increased $6 million for the three months ended March 31, 2018, as compared to the three months ended March 31, 2017, primarily due to the accretive impact of non-cash adjustments to net income, partially offset by unfavorable working capital changes.

43

Table of Contents


NET CASH USED IN INVESTING ACTIVITIES
Cash used in investing activities for the three months ended March 31, 2018 consisted primarily of our investment in Core of $18 million and purchases of property, plant and equipment of $41 million.
Cash used in investing activities for the three months ended March 31, 2017 consisted primarily of cash paid in connection with our Bai Brands Merger of $1,548 million and purchases of property, plant and equipment of $16 million.
NET CASH USED IN FINANCING ACTIVITIES
Cash used in financing activities for the three months ended March 31, 2018 consisted primarily of dividend payments of $104 million and tax withholding payments related to net shares settlement of $21 million. The overall cash outflow was partially offset by proceeds from commercial paper of $54 million.
Net cash used in financing activities for the three months ended March 31, 2017 consisted primarily of dividend payments of $97 million and stock repurchases of $28 million.
Debt Ratings
As of March 31, 2018, our credit ratings were as follows:
Rating Agency
Long-Term Debt Rating
Commercial Paper Rating
Outlook
Date of Last Change
Moody's
Baa1
P-2
Possible Downgrade
January 29, 2018
S&P
BBB+
A-2
Watch Negative
January 29, 2018
____________________________
(1)
As a result of the Maple Transaction, Moody's and S&P have changed their outlook. Moody's has placed DPS ratings under review for downgrade and S&P has placed DPS as Creditwatch Negative.
These debt and commercial paper ratings impact the interest we pay on our financing arrangements. A downgrade of one or both of our debt and commercial paper ratings could increase our interest expense and decrease the cash available to fund anticipated obligations.
Capital Expenditures
Capital expenditures were $41 million for the three months ended March 31, 2018. Capital expenditures were primarily related to machinery and equipment, replacement of existing cold drink equipment, IT equipment and fleet.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, cash equivalents, restricted cash and restricted cash equivalents decreased $37 million since December 31, 2017 to $121 million as of March 31, 2018, primarily driven by capital expenditures, as operating cash flows were almost fully offset by dividends paid.
Our cash balances are used to fund working capital requirements, scheduled debt and interest payments, capital expenditures, income tax obligations and dividend payments. Cash generated by our foreign operations is generally repatriated to the U.S. periodically as working capital funding requirements in those jurisdictions allow. Foreign cash balances, which includes restricted cash, were $24 million and $46 million as of March 31, 2018 and December 31, 2017, respectively. We accrue tax costs for repatriation, as applicable, as cash is generated in those foreign jurisdictions.
Acquisitions and Investments
We have shown a disciplined approach to strategic investments in certain allied brands to enhance our position in premium and high growth categories and strengthen our existing distribution partnerships. We may make future equity investments in allied brands and/or acquisitions of regional bottling companies, distributors and/or distribution rights to further extend our geographic coverage. Any acquisitions may require additional funding for future capital expenditures and possibly restructuring expenses. Refer to Note 2 for additional information.


44

Table of Contents


Total Shareholder Distributions
tsr331.jpg
Our Board declared dividends aggregating $0.58 per share on outstanding common stock for each period during the three months ended March 31, 2018 and 2017. Our share repurchase program was suspended during the three months ended March 31, 2018. Refer to Part II, Item 2 of this Quarterly Report on Form 10-Q for additional information regarding these repurchases.
The following chart details these payments during the three months ended March 31, 2018 and 2017.
Contractual Commitments and Obligations
We enter into various contractual obligations that impact, or could impact, our liquidity. Based on our current and anticipated level of operations, we believe that our proceeds from operating cash flows will be sufficient to meet our anticipated obligations. To the extent that our operating cash flows are not sufficient to meet our liquidity needs, we may utilize cash on hand or amounts available under our financing arrangements, if necessary.
The following table summarizes our contractual obligations and contingencies, as of March 31, 2018, that have significantly changed from the amounts disclosed in our Annual Report on Form 10-K:
 
Payments Due in Year
 (in millions)
Total
 
2018
 
2019
 
2020
 
2021
 
2022
 
After 2022
Commercial paper
$
120

 
$
120

 
$

 
$

 
$

 
$

 
$

Purchase obligations(1)(2)
1,355

 
654

 
194

 
149

 
104

 
85

 
169

____________________________
(1)
Amounts represent payments under agreements to purchase goods or services that are legally binding and that specify all significant terms, including capital obligations and long-term contractual obligations.
(2)
Amounts do not include the $45 million transaction fee to our financial advisor that is contingent upon the consummation of the Maple Transaction.
Through March 31, 2018, there have been no other material changes to the amounts disclosed in our Annual Report on Form 10-K.
OFF-BALANCE SHEET ARRANGEMENTS
There have been no material changes in off-balance sheet arrangements from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017.
EFFECT OF RECENT ACCOUNTING PRONOUNCEMENTS
Refer to Note 1 of the Notes to our Unaudited Condensed Consolidated Financial Statements for a discussion of recently issued accounting standards and recently adopted provisions of U.S. GAAP.

45

Table of Contents


ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risks arising from changes in market rates and prices, including movements in foreign currency exchange rates, interest rates and commodity prices. From time to time, we may enter into derivatives or other financial instruments to hedge or mitigate commercial risks. We do not enter into derivative instruments for speculation, investing or trading.
Foreign Exchange Risk
The majority of our net sales, expenses and capital purchases are transacted in U.S. dollars. However, we have exposure with respect to foreign exchange rate fluctuations. Our primary exposure to foreign exchange rates is the Canadian dollar and Mexican peso against the U.S. dollar. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses in our income statement as incurred. As of March 31, 2018, the impact to our income from operations of a 10% change (up or down) in exchange rates is estimated to be an increase or decrease of approximately $21 million on an annual basis.
We use derivative instruments such as foreign exchange forward contracts to manage a portion of our exposure to changes in foreign exchange rates. As of March 31, 2018, we had derivative contracts outstanding with a notional value of $49 million maturing at various dates through December 17, 2018.
Interest Rate Risk
We centrally manage our debt portfolio through the use of interest rate swaps and monitor our mix of fixed-rate and variable rate debt. As of March 31, 2018, the carrying value of our fixed-rate debt, excluding capital lease obligations, was $4,212 million, $1,070 million of which is designated in fair value hedging relationships and exposed to variability in interest rates.
The following table is an estimate of the impact to the interest rate swaps that could result from hypothetical interest rate changes during the term of the financial instruments, based on debt levels as of March 31, 2018:
Sensitivity Analysis
Hypothetical Change in Interest Rates(1)
 
Annual Impact to Interest Expense
 
Change in Fair Value(2)
1-percent decrease
 
$11 million decrease
 
$46 million increase
1-percent increase
 
$11 million increase
 
$43 million decrease
____________________________
(1)
We pay an average floating rate, which fluctuates periodically, based on LIBOR and a credit spread, as a result of designated fair value hedges on certain debt instruments. See Note 7 of the Notes to our Unaudited Condensed Consolidated Financial Statements for further information.
(2) See Note 7 of the Notes to our Unaudited Condensed Consolidated Financial Statements for quantification of those derivative positions.
Commodity Risks
We are subject to market risks with respect to commodities because our ability to recover increased costs through higher pricing may be limited by the competitive environment in which we operate. Our principal commodities risks relate to our purchases of PET, aluminum, diesel fuel, corn (for high fructose corn syrup), apple juice concentrate, apples, sucrose and natural gas (for use in processing and packaging).
We utilize commodities forward and future contracts and supplier pricing agreements to hedge the risk of adverse movements in commodity prices for limited time periods for certain commodities. The fair market value of these contracts as of March 31, 2018 was a net asset of $32 million.
As of March 31, 2018, the impact of a 10% change (up or down) in market prices for these commodities where the risk of adverse movements has not been hedged is estimated to have an $18 million impact on our income from operations for the remainder of 2018.
ITEM 4. Controls and Procedures
Based on evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act) our management, including our Chief Executive Officer and Chief Financial Officer, has concluded that, as of March 31, 2018, our disclosure controls and procedures are effective to (i) provide reasonable assurance that information required to be disclosed in the Exchange Act filings is recorded, processed, summarized and reported within the time periods specified by the SEC's rules and forms, and (ii) ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act are accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
No change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) occurred during the quarter ended March 31, 2018 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

46

Table of Contents


PART II – OTHER INFORMATION
ITEM 1. Legal Proceedings
We are occasionally subject to litigation or other legal proceedings relating to our business. See Note 14 of the Notes to our Unaudited Condensed Consolidated Financial Statements for more information related to commitments and contingencies, which is incorporated herein by reference.
ITEM 1A. Risk Factors
There have been no material changes that we are aware of from the risk factors set forth in Part I, Item 1A in our Annual Report for the year ended December 31, 2017.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
The Board has authorized the Company to repurchase an aggregate amount of up to $5 billion of our outstanding common stock in prior years. This authorization has no expiration date. As of March 31, 2018, there was a remaining balance of approximately $733 million authorized for repurchase that had not been utilized.
The Company's share repurchase program was suspended during negotiation of the Maple Transaction and it remains suspended as of March 31, 2018 under the terms of the Merger Agreement. The Company therefore did not repurchase any shares during the three months ended March 31, 2018.

47

Table of Contents


ITEM 6. Exhibits
Separation and Distribution Agreement between Cadbury Schweppes plc and Dr Pepper Snapple Group, Inc. and, solely for certain provisions set forth therein, Cadbury plc, dated as of May 1, 2008 (filed as Exhibit 2.1 to the Company's Current Report on Form 8-K (filed on May 5, 2008) and incorporated herein by reference).
Agreement and Plan of Merger, dated as of November 21, 2016, by and among Bai Brands LLC, Dr Pepper Snapple Group, Inc., Superfruit Merger Sub, LLC and Fortis Advisors LLC, (filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K (filed on November 23, 2016) and incorporated herein by reference).
Amendment No. 1, dated as of January 31, 2017, to the Agreement and Plan of Merger, dated as of November 21, 2016, by and among Bai Brands LLC, Dr Pepper Snapple Group, Inc., Superfruit Merger Sub, LLC and Fortis Advisors LLC, (filed as Exhibit 2.2 to the Company’s Current Report on Form 8-K (filed on January 31, 2017) and incorporated herein by reference).
Agreement and Plan of Merger, dated as of January 29, 2018, by and among Dr Pepper Snapple Group, Inc., Maple Parent Holdings Corp. and Salt Merger Sub, Inc. (filed as Exhibit 2.1 to the Company's Current Report on Form 8-K (filed on January 31, 2018) and incorporated herein by reference).
Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K (filed on May 12, 2008) and incorporated herein by reference).
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. effective as of May 17, 2012 (filed as Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q (filed July 26, 2012) and incorporated herein by reference).
Certificate of Second Amendment to Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. effective as of May 19, 2016 (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K (filed May 20, 2016) and incorporated herein by reference.
Amended and Restated By-Laws of Dr Pepper Snapple Group, Inc. effective as of January 25, 2016 (filed as Exhibit 3.2 to the Company's Current Report on Form 8-K (filed January 25, 2016) and incorporated herein by reference).
Indenture, dated April 30, 2008, between Dr Pepper Snapple Group, Inc. and Wells Fargo Bank, N.A. (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on May 1, 2008) and incorporated herein by reference).
Form of 6.12% Senior Notes due 2013 (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on May 1, 2008) and incorporated herein by reference).
Form of 6.82% Senior Notes due 2018 (filed as Exhibit 4.3 to the Company's Current Report on Form 8-K (filed on May 1, 2008) and incorporated herein by reference).
Form of 7.45% Senior Notes due 2038 (filed as Exhibit 4.4 to the Company's Current Report on Form 8-K (filed on May 1, 2008) and incorporated herein by reference).
Registration Rights Agreement, dated April 30, 2008, between Dr Pepper Snapple Group, Inc., J.P. Morgan Securities Inc., Banc of America Securities LLC, Goldman, Sachs & Co., Morgan Stanley & Co. Incorporated, UBS Securities LLC, BNP Paribas Securities Corp., Mitsubishi UFJ Securities International plc, Scotia Capital (USA) Inc., SunTrust Robinson Humphrey, Inc., Wachovia Capital Markets, LLC and TD Securities (USA) LLC (filed as Exhibit 4.5 to the Company's Current Report on Form 8-K (filed on May 1, 2008) and incorporated herein by reference).
Registration Rights Agreement Joinder, dated May 7, 2008, by the subsidiary guarantors named therein (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on May 12, 2008) and incorporated herein by reference).
Supplemental Indenture, dated May 7, 2008, among Dr Pepper Snapple Group, Inc., the subsidiary guarantors named therein and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on May 12, 2008) and incorporated herein by reference).
Second Supplemental Indenture dated March 17, 2009, to be effective as of December 31, 2008, among Splash Transport, Inc., as a subsidiary guarantor, Dr Pepper Snapple Group, Inc., and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.8 to the Company's Annual Report on Form 10-K (filed on March 26, 2009) and incorporated herein by reference).
Third Supplemental Indenture, dated October 19, 2009, among 234DP Aviation, LLC, as a subsidiary guarantor; Dr Pepper Snapple Group, Inc., and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.9 to the Company's Quarterly Report on Form 10-Q (filed November 5, 2009) and incorporated herein by reference).
Fourth Supplemental Indenture, dated as of January 31, 2017, among Bai Brands LLC, a New Jersey limited liability company, 184 Innovations Inc., a Delaware corporation (each as a new subsidiary guarantors under the Indenture dated April 30, 2008 (as referenced in Item 4.1 in this Exhibit Index), Dr Pepper Snapple Group, Inc., each other then-existing Guarantor under the Indenture and Wells Fargo, National Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed February 2, 2017) and incorporated herein by reference).
Indenture, dated as of December 15, 2009, between Dr Pepper Snapple Group, Inc. and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on December 23, 2009) and incorporated herein by reference).
Second Supplemental Indenture, dated as of January 11, 2011, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on January 11, 2011) and incorporated herein by reference).
2.90% Senior Note due 2016 (in global form), dated January 11, 2011, in the principal amount of $500 million (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on January 11, 2011) and incorporated herein by reference).

48

Table of Contents


Third Supplemental Indenture, dated as of November 15, 2011, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on November 15, 2011) and incorporated herein by reference).
2.60% Senior Note due 2019 (in global form), dated November 15, 2011, in the principal amount of $250 million (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on November 15, 2011) and incorporated herein by reference).
3.20% Senior Note due 2021 (in global form), dated November 15, 2011, in the principal amount of $250 million (filed as Exhibit 4.3 to the Company's Current Report on Form 8-K (filed on November 15, 2011) and incorporated herein by reference).
Fourth Supplemental Indenture, dated as of November 20, 2012, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on November 20, 2012) and incorporated herein by reference).
2.00% Senior Note due 2020 (in global form), dated November 20, 2012, in the principal amount of $250 million (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on November 20, 2012) and incorporated herein by reference).
2.70% Senior Note due 2022 (in global form), dated November 20, 2012, in the principal amount of $250 million (filed as Exhibit 4.3 to the Company's Current Report on Form 8-K (filed on November 20, 2012) and incorporated herein by reference).
Fifth Supplemental Indenture, dated as of November 9, 2015, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on November 10, 2015) and incorporated herein by reference).
3.40% Senior Note due 2025 (in global form), dated November 9, 2015, in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on November 10, 2015) and incorporated herein by reference).
4.50% Senior Note due 2045 (in global form), dated November 9, 2015, in the principal amount of $250,000,000 (filed as Exhibit 4.3 to the Company's Current Report on Form 8-K (filed on November 10, 2015) and incorporated herein by reference).
Sixth Supplemental Indenture, dated as of September 16, 2016, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on September 16, 2016) and incorporated herein by reference).
2.55% Senior Note due 2026 (in global form), dated September 16, 2016, in the principal amount of $400,000,000 (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on September 16, 2016) and incorporated herein by reference).
Seventh Supplemental Indenture, dated as of December 14, 2016, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on December 14, 2016) and incorporated herein by reference).
2.53% Senior Note due 2021 (in global form), dated December 14, 2016, in the principal amount of $250,000,000 (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on December 14, 2016) and incorporated herein by reference).
3.13% Senior Note due 2023 (in global form), dated December 14, 2016, in the principal amount of $500,000,000 (filed as Exhibit 4.3 to the Company's Current Report on Form 8-K (filed on December 14, 2016) and incorporated herein by reference).
3.43% Senior Note due 2027 (in global form), dated December 14, 2016, in the principal amount of $400,000,000 (filed as Exhibit 4.4 to the Company's Current Report on Form 8-K (filed on December 14, 2016) and incorporated herein by reference).
4.42% Senior Note due 2046 (in global form), dated December 14, 2016, in the principal amount of $400,000,000 (filed as Exhibit 4.5 to the Company's Current Report on Form 8-K (filed on December 14, 2016) and incorporated herein by reference).
Eighth Supplemental Indenture, dated as of January 31, 2017, among Bai Brands LLC, a New Jersey limited liability company, 184 Innovations Inc., a Delaware corporation (each as a new subsidiary guarantor under the Indenture dated April 30, 2008 (as referenced in Item 4.1 in this Exhibit Index), Dr Pepper Snapple Group, Inc., each other then-existing Guarantor under the Indenture) and Wells Fargo, National Bank, N.A., as trustee (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on February 2, 2017) and incorporated herein by reference).
Ninth Supplemental Indenture, dated as of June 15, 2017, among Dr Pepper Snapple Group, Inc., the guarantors party thereto, and Wells Fargo Bank, N.A., as trustee (filed as Exhibit 4.1 to the Company's Current Report on Form 8-K (filed on June 15, 2017) and incorporated herein by reference).
Registration Rights Agreement, dated June 15, 2017, between Dr Pepper Snapple Group, Inc., Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC (filed as Exhibit 4.2 to the Company's Current Report on Form 8-K (filed on June 15, 2017) and incorporated herein by reference).
Computation of Ratio of Earnings to Fixed Charges.
Certification of Chief Executive Officer of Dr Pepper Snapple Group, Inc. pursuant to Rule 13a-14(a) or 15d-14(a) promulgated under the Exchange Act.
Certification of Chief Financial Officer of Dr Pepper Snapple Group, Inc. pursuant to Rule 13a-14(a) or 15d-14(a) promulgated under the Exchange Act.

49

Table of Contents


Certification of Chief Executive Officer of Dr Pepper Snapple Group, Inc. pursuant to Rule 13a-14(b) or 15d-14(b) promulgated under the Exchange Act, and Section 1350 of Chapter 63 of Title 18 of the United States Code.
Certification of Chief Financial Officer of Dr Pepper Snapple Group, Inc. pursuant to Rule 13a-14(b) or 15d-14(b) promulgated under the Exchange Act, and Section 1350 of Chapter 63 of Title 18 of the United States Code.
101*
The following financial information from Dr Pepper Snapple Group, Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three months ended March 31, 2018 and 2017, (ii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2018 and 2017, (iii) Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017, (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2018 and 2017, (v) Condensed Consolidated Statement of Changes in Stockholders' Equity for the three months ended March 31, 2018, and (vi) the Notes to Condensed Consolidated Financial Statements.
* Filed herewith.
** Furnished herewith.

50

Table of Contents


SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Dr Pepper Snapple Group, Inc.
 
 
 
 
 
 
 
By:
/s/ Martin M. Ellen
 
 
 
 
 
 
Name:
 
Martin M. Ellen
 
 
Title:
 
Executive Vice President and Chief Financial
 
 
 
 
Officer of Dr Pepper Snapple Group, Inc.
 
Date: April 25, 2018
 
 
 
 


51
Exhibit 12.1

DR PEPPER SNAPPLE GROUP, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(In millions, except ratio amounts)
 
For the Three Months Ended March 31,
 
For the Years Ended December 31,
 
2018
 
2017
 
2016
 
2015
 
2014
Calculation of fixed charges ratio:
 
 
 
 
 
 
 
 
 
Income before provision for income taxes, equity in (loss) earnings of unconsolidated subsidiaries and cumulative effect of change in accounting policy
$
219

 
$
1,173

 
$
1,283

 
$
1,184

 
$
1,073

 
 
 
 
 
 
 
 
 
 
Add/(deduct):
 
 
 
 
 
 
 
 
 
Fixed charges
45

 
181

 
164

 
132

 
125

Amortization of capitalized interest

 
3

 
3

 
3

 
4

Capitalized interest

 
(1
)
 
(3
)
 
(1
)
 
(2
)
Total earnings available for fixed charges
$
264

 
$
1,356

 
$
1,447

 
$
1,318

 
$
1,200

 
 
 
 
 
 
 
 
 
 
Fixed charges:
 
 
 
 
 
 
 
 
 
Interest expense
$
41

 
$
164

 
$
147

 
$
117

 
$
109

Capitalized interest

 
1

 
3

 
1

 
2

Interest component of rental expense(1)
4

 
16

 
14

 
14

 
14

Total fixed charges
$
45

 
$
181

 
$
164

 
$
132

 
$
125

 
 
 
 
 
 
 
 
 
 
Ratio of earnings to fixed charges
5.8x

 
7.5x

 
8.8x

 
10.0x

 
9.6x

_________________________________
(1)
Represents a reasonable estimate of the interest component of rental expense incurred by us.

 





Exhibit 31.1

Principal Executive Officer's Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Larry D. Young, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Dr Pepper Snapple Group, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


 
/s/ Larry D. Young
 
Date: April 25, 2018
Larry D. Young 
 
 
President and Chief Executive Officer of
Dr Pepper Snapple Group, Inc. 
 
 





Exhibit 31.2

Principal Financial Officer's Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Martin M. Ellen, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Dr Pepper Snapple Group, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
/s/ Martin M. Ellen
 
Date: April 25, 2018
Martin M. Ellen
 
 
Executive Vice President and Chief Financial Officer of
Dr Pepper Snapple Group, Inc. 
 
 





Exhibit 32.1

Certification Pursuant To 18 U.S.C. Section 1350,
As Adopted Pursuant To
Section 906 of the Sarbanes-Oxley Act of 2002

     I, Larry D. Young, President and Chief Executive Officer of Dr Pepper Snapple Group, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)
the Quarterly Report on Form 10-Q of the Company for the first quarterly period ended March 31, 2018, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Larry D. Young
 
Date: April 25, 2018
Larry D. Young 
 
 
President and Chief Executive Officer of
Dr Pepper Snapple Group, Inc. 
 
 





Exhibit 32.2

Certification Pursuant To 18 U.S.C. Section 1350,
As Adopted Pursuant To
Section 906 of the Sarbanes-Oxley Act of 2002

     I, Martin M. Ellen, Executive Vice President and Chief Financial Officer of Dr Pepper Snapple Group, Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)
the Quarterly Report on Form 10-Q of the Company for the first quarterly period ended March 31, 2018, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
/s/ Martin M. Ellen
 
Date: April 25, 2018
Martin M. Ellen
 
 
Executive Vice President and Chief Financial Officer of Dr Pepper Snapple Group, Inc. 
 
 



Categories

SEC Filings